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ABSTRACT 
 
Multiple sclerosis (MS) is a debilitating disease characterized by demyelination 
and neurodegeneration in the CNS. Both activated microglia and infiltrating myeloid 
cells are thought to contribute to disease progression of experimental autoimmune 
encephalomyelitis (EAE), a widely used animal model of MS. Signal transducer and 
activator of transcription 3 (STAT3) regulates multiple cellular functions including cell 
differentiation, survival, and inflammation, and is a critical signaling molecule for the 
interleukin-6 family of cytokines. Additionally, not only Stat3 is a risk factor for MS, but 
its increased phosphorylation has been detected in the MS patient myeloid cells.  
To investigate the role of STAT3 in myeloid cells and neuroinflammation, we 
generated myeloid STAT3-deficient mice (LysMcre/Stat3fl/fl) and investigated their 
susceptibility to MOG35-55-induced EAE. Whereas Stat3
fl/fl control mice developed 
typical symptoms of EAE, LysMcre/Stat3fl/fl mice rather resistant to EAE and exhibited 
diminished antigen-specific helper T-cell responses in the periphery. Splenic myeloid 
cells isolated from immunized LysMcre/Stat3fl/fl mice exhibited impaired antigen-
presenting and co-stimulatory functions. In contrast to active EAE, LysMcre/Stat3fl/fl 
mice were partially susceptible to EAE induced by adoptive transfer of encephalitogenic 
T-cells, suggesting the importance of myeloid STAT3 in differentiation of helper T-cells 
during the initiation phase of EAE. Consistent with these findings, mice with STAT3 
inactivated in microglial cells were indistinguishable from control mice in MOG35-55-
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induced EAE, suggesting that microglial STAT3 signaling does not play a critical role in 
EAE. 
We also investigated the role of microglial STAT3 on brain development and 
behaviors. Our preliminary investigation indicated that neonatal inactivation of 
microglial STAT3 signaling resulted in a transient reduction of microglial number at the 
second postnatal week, although the microglial population was largely recovered by P30. 
In addition, the Cx3cr1creER/Stat3fl/fl mice exhibited altered marble burying behaviors. 
These results suggest that microglial STAT3 signaling plays important roles in normal 
postnatal brain development and that transient perturbation of microglial functions may 
have long-term functional consequences. 
 In summary, this study highlights the importance of STAT3-dependent pathways 
in myeloid cells in the development of autoimmunity during EAE, as well as STAT3 in 
microglia in postnatal brain development and behaviors. 
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1. INTRODUCTION  
 
1.1 Multiple Sclerosis 
1.1.1 Overview of Multiple Sclerosis 
Multiple sclerosis (MS) is a debilitating disease characterized by demyelination 
and neurodegeneration in the CNS, and was first described in detail by Charcot in 1868 
[1]. Its prevalence is 0.09% of human population worldwide [2], has unknown etiology 
and likely involves with genetics and environmental factors. Its occurrence is higher in 
the further away from the equator, and as determined by migration studies, is not 
accounted for solely by population genetics [3]. Its prevalence is also correlated with the 
socioeconomic level of the country, and is hypothesized to relate to the delayed exposure 
of infections during childhood, known as the hygiene hypothesis [4]. It occurs in more 
females than males with the ratio being roughly 2:1, suggesting hormones as one of the 
risk factors [2]. The first onset of MS is usually between age 20-40 [5]. Patients 
experience a wide array of symptoms including vision problems, numbness, vertigo, 
ataxia, and more. Most patients initially undergo a relapse-remitting stage (RRMS), in 
which neurological symptoms occur and last a few days before remission. Later in life, 
most patients undergo a secondary progressive stage (SPMS), in which the symptoms 
and lesions grow progressively worse and become irresponsive to treatments [4, 6]. 
There is also a primary progressive form of MS (PPMS) that occurs in roughly 10% - 
15% of the patients [7], in which the patients do not undergo the relapse-remitting stage, 
but instead directly enter the progressive stage and exhibit continuously worsening 
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symptoms.  During RRMS, T2-hyperintense lesions commonly occur in the 
periventricular white matter regions, indicating a wide variety of pathologies such as 
inflammation, demyelination, and axonal loss, whereas T1-hypointense lesions are 
common in the supratentorial brain regions and indicate brain atrophy [8]. MS lesions in 
the CNS are multifocal and heterogeneous in nature and can be characterized into 
several groups based on distribution of immune cells and other criteria [9]. Specifically, 
the lesions are characterized into groups that feature autoimmune encephalomyelitis and 
groups that feature oligodendrocyte dystrophy [9], suggesting the possible involvement 
of multiple different mechanisms. 
1.1.2 Genetic Risks of MS 
The cause of MS is not completely clear. The fact that MS is heterogeneous in 
both its symptoms and pathologies suggest it may involve multiple different 
mechanisms. MS is widely known to have a genetic component, as it has a modest 
familial risk [10]. The concordance rate of MS in female homozygotic twins has been 
determined to be around 25% [11], strongly suggesting that MS has genetic association 
to some degree but non-genetic factors are also involved. Genome-wide association 
studies have shown that MS susceptibility is linked to many different genes on multiple 
different chromosomes, and many are related to immune functions, such as TNFα, IFNγ, 
IL-2R, IL-7R, IL-10, CCR2, CCR5, ICAM-1, CTLA-4, and STAT3 [4, 12]. Alleles in 
the HLA complex confers the biggest genetic risk factor [13]. HLA alleles associated 
with MS susceptibility may have binding properties with better affinity to self-myelin 
antigen. When transgenic mice co-express certain HLA alleles associated with MS and 
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myelin basic protein (MBP)-specific T-cell receptor (TCR) derived from MS patients, 
the mice develop spontaneous experimental autoimmune encephalomyelitis (EAE) [14, 
15]. These studies provide strong evidence that MS is related to genetics that influence 
the immune functions. 
1.1.3 MS and Autoimmunity 
According to Witebsky’s postulate and Rose and Bona’s revision of the criteria 
for autoimmune-mediated diseases, the transfer of autoantibodies or autoimmune T-cells 
to another healthy host must be sufficient to reproduce the disease [16, 17]. However, 
due to ethical concerns, it would be difficult to provide direct proof that MS is an 
autoimmune-mediated disease. While this is the case, many studies provide indirect 
evidence that MS has an autoimmune component. For example, autoimmune T-cells can 
be found in the cerebrospinal fluid (CSF) of the MS patients [18]. Infiltrating myeloid 
cells and lymphocytes were found to be associated with lesion areas [19]. HLA alleles, 
responsible for interaction with the antigens and lymphocytes, represent the strongest 
genetic risk [13]. Immunosuppressive therapies such as glatiramer acetate and 
mitoxantrone help relieving the symptoms during relapse [20] [21]. In addition, 
natalizumab, which blocks α4β1 integrin and T-cell infiltration, as well as fingolimod, 
which prevents lymphocytes from leaving the secondary lymphoid organs, are both 
effective treatments [22, 23]. Given the number of studies and the common use of 
immunosuppressive therapies, today MS is widely acknowledged to be an autoimmune 
disease. 
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1.1.4 Environmental Factors of MS 
Although many genes have been identified to be related to MS susceptibility, the 
concordance rate in homozygotic twins is only 25%, meaning that the onset of MS 
cannot be explained solely by genetics. Moreover, the latitude difference in MS 
prevalence cannot be explained by population genetics, as migration to a region of 
higher or lower prevalence before the age of 15-16 years old grants the associated higher 
or lower risk in that region [24]. These studies suggest that there are likely 
environmental triggers associated with MS onset. As reviewed by Sospedra and Martin 
[4], a number of viruses exists that cause demyelinating diseases in human as well as 
other animals. It is possible that through the mechanisms of molecular mimicry and 
bystander activation, viral infection could lead to breakage of immune tolerance and 
cause autoimmunity. While the theory seems plausible and several viral candidates exist, 
thus far no single virus has been identified to cause MS. 
1.1.5 Animal Models of MS 
Due to the complex nature of MS, different animal models are used to help 
understand different aspects of MS. For example, toxin-induced models such as 
cuprizone and lysolecithin help to understand the process of demyelination, injury 
responses, and remyelination [25, 26]; Virus-based models such as Theiler’s murine 
encephalomyelitis virus (TMEV) aim to understand possible environmental cause by 
viral infection and is clinically relevant to primary progressive MS [27]; Autoimmune-
driven models such as EAE excels at studying the autoimmune aspect of the disease. 
EAE was originally developed to study acute disseminated encephalomyelitis (ADEM) 
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[28]. Since then, EAE has gradually become the most widely used model for MS and has 
led to successful immunosuppressive/immunomodulatory therapies such as glatiramer 
acetate, natalizumab, and fingolimod. Although MS likely has a different etiology than 
EAE, EAE is still a very valuable tool in terms of studying the process of CD4+ T-cell 
mediated autoimmunity and cell trafficking, which are the major aims of this study. 
 
1.2 Experimental Autoimmune Encephalomyelitis 
1.2.1 The Origin of Experimental Autoimmune Encephalomyelitis 
Experimental autoimmune encephalomyelitis (EAE), the most widely used and 
accepted animal model of MS, was first described by Rivers and others [28, 29] in 
attempt to experimentally produce acute disseminated encephalomyelitis (ADEM). 
ADEM occurs in the recovery stage after certain viral diseases, e.g., smallpox and 
measles, as well as after rabies vaccination [30]. Patients typically exhibit limb paresis 
and fast recovery, but more severe cases can cause mortality [30]. Its pathology is 
characterized by demyelination and perivascular infiltration [30]. Because ADEM only 
occurs in rare cases, Rivers and others attempted repeated injections of rabies vaccine 
component in monkeys. Surprisingly, in monkeys receiving uninfected rabbit brain as a 
control, ADEM-like symptoms occurred with perivascular infiltration and 
demyelination. Although the authors did not know whether the experimental disease 
they created was really ADEM itself (as would occurred after rabies vaccination), their 
studies indicate that a specific immune response in the CNS, autoimmune or allergic, 
may be elicited using exogenous CNS tissue. 
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Because Rivers and others’ work required many injections to achieve a decent 
disease onset rate, other studies started using the complete Freund’s adjuvant (CFA), 
which contains killed Mycobacterium tuberculosis in an oil-based emulsion, along with 
the brain emulsions [31, 32]. The use of CFA made the induction much more reliable. 
The monkeys developed relapsing-remitting symptoms with leukocyte infiltration into 
the perivascular space. Soon after, EAE with brain homogenates were produced in other 
animals including mice, which was first described by Olitsky and Yager [33] and used 
homologous brain tissue and CFA. 
Because demyelination is a common feature in EAE, hypotheses arose that 
autoimmunity to the myelin component is what causes the disease. Laatsch, Kies [34] 
isolated myelin and found that it possesses greater disease-causing capability than whole 
brain homogenate. Since then, myelin basic protein (MBP) and subsequently other 
myelin proteins such as proteolipid protein (PLP) and myelin oligodendrocyte 
glycoprotein (MOG) and their derived epitopes were discovered and used to generate 
EAE in different mouse strains. For example, whole MBP, whole PLP, and several of 
their peptides containing encephalitogenic epitopes can be used in SJL mice to cause 
relapsing-remitting EAE, whereas MOG35-55 can be used in C57BL/6 mice to cause 
monophasic chronic EAE [35]. 
1.2.2 Disease Mechanisms of EAE 
Since CFA contains ligands for Toll-like receptors and elicit a strong immune 
response [36], myelin antigen emulsified in CFA become phagocytosed by the activated 
professional antigen presenting cells (APCs), processed and presented on MHC Class II 
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molecules in the draining lymph nodes [37]. Through the interaction of antigen 
presentation, co-stimulation, and cytokine crosstalk, naïve helper T-cells proliferate and 
differentiate into effector T-cells (Figure 1). Co-stimulation involves recognition of 
CD80/CD86 on APCs to CD28 on T cells as well as CD40 to CD154 [38]. The cytokine 
interleukin (IL)-12 from APCs drives T cells towards TH1 subset, whereas a combination 
of IL-6 and transforming growth factor β (TGFβ) drives towards TH17 subset [39]. In 
other words, an adaptive immune response is induced artificially, much like the process 
of vaccination.  
 
 
Figure 1. Antigen-specific interaction between APCs and helper T-cells.  
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Activated T cells travel to the CNS, where they meet their target antigen. In 
regards to the access of T cells to the CNS, it is generally believed that the pertussis 
toxin (PT) used in MOG-induced EAE in C57BL/6 mice as well as MBP-induced EAE 
in SJL mice is required at the time of induction because it opens the blood brain barrier 
(BBB) to allow leukocytes to pass through and cause damage [40]. However, this does 
not explain why PLP-induced EAE in SJL mice does not require PT, despite that these 
EAE models essentially work in the same principles. Moreover, since PT is administered 
at the time of induction and 48 hours later, by the time the effector T cells are in the 
circulation, which takes roughly a week, the transient effect of PT on BBB should have 
diminished already [40]. Thus, it is conceivable that the role of PT in EAE induction 
may not be about BBB permeability. PT is an exotoxin derived from the bacterium 
Bordetella pertussis, and is involved in inhibiting macrophage and neutrophil 
recruitment by altering chemokine secretion during whooping cough [41]. It is also a G 
protein couple receptor antagonist and has other different actions [42]. Furthermore, it 
was reported that PT-induced production of IL-1β is required for the clonal expansion of 
helper T-cells [43]. Therefore, PT is likely to exert its effect on cytokine signaling 
during EAE induction. 
Although the exact mechanism about how the autoreactive T cells gain entry to 
the healthy CNS (as the case in EAE) is not completely understood, evidence points 
towards APC and T-cell interaction in the leptomeninges. Kivisakk, Mahad [44] found 
that memory T-cells regularly enter the cerebrospinal fluid (CSF) in the subarachnoid 
space through choroid plexus via P-selectin/ligand and ICAM-1/LFA-1 interaction for 
 9 
 
purpose of immune surveillance. Later the same group [45] isolated macrophages and 
dendritic cells from meninges in animals before EAE onset, co-cultured with naïve 2D2 
T cells in the presence of MOG, and found that the T cells did proliferate. With BrdU 
injected prior to disease onset, they found T cells were proliferating in the meninges in 
pre-clinical animals. Using time-lapsed microscopy on isolated meninges stained with 
cell markers, the authors found close interactions between APCs and T cells. Their 
findings suggest a possible mechanism by which EAE develops: Autoimmune T cells 
polarized in the peripheral immune organs move to the CSF for daily surveillance, where 
they meet local macrophages and dendritic cells which are presenting antigens drained 
and collected from the interstitial fluid in the CNS. The interaction of MOG presented on 
MHC II and MOG-specific T-cells triggers T-cell reactivation and thereby causing 
meningitis. The local inflammation caused tissue damage and activated adjacent 
macrophages and microglia, which then secreted proinflammatory cytokines and 
chemokines and MMPs, causing disruption of BBB and infiltration of leukocytes into 
the CNS parenchyma. Consistent with this hypothesis, it was demonstrated in a rat EAE 
model that effector T-cells can move along the CSF, encounter the interaction with 
APCs in the leptomeninges, and gain access to the parenchyma [46]. In addition, 
lymphatic vessels that run along the dural sinuses in the CNS has been recently 
discovered [47]. These lymphatic vessels are connected to the cervical lymph nodes and 
can carry immune cells to the CSF, where the cells conduct immune surveillance.  
EAE is mediated by CD4+ T-cells, as evidenced not only by the fact that TH1 and 
TH17 subsets are necessary for the disease’s development [48, 49], but also that adoptive 
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transfer of differentiated MOG-specific T cells is sufficient to trigger EAE [50]. Both 
TH1 [49] and TH17 subsets [48] were shown to be important in the pathogenesis. 
Through proinflammatory cytokine crosstalk with microglia and recruited 
macrophages/monocytes, the immune response causes damage to the myelin and other 
structures in the CNS. 
1.2.3 Strengths and Pitfalls of EAE 
Studies in EAE have proven to have tremendous benefits in our understanding of 
demyelination. EAE is not only a good model for ADEM, but also a good model for 
studying autoimmunity. It has led to the discovery of TH17 subset of helper T-cells [48]. 
It has enabled studies in the contribution of various immune cell types, numerous 
cytokines, and other molecules in autoimmunity. It has helped the understanding of 
genetic susceptibility in autoimmunity. It has led to many studies on cell trafficking into 
the CNS, from the role of matrix metalloproteinases [51, 52] to T-cell immune 
surveillance in the CSF [44, 45], and has advanced our understanding of the BBB and 
the so-called CNS immune privilege. On the practical side, EAE has allowed the 
development of several successful immunosuppressive/immunomodulatory therapies, 
e.g., glatiramer acetate (GA), natalizumab, and fingolimod. GA was originally 
developed as a random copolymer of 4 amino acids to mimic MBP [20]. It was shown to 
suppress EAE, has immunomodulatory properties such as inducing M2 and TH2 
phenotypes, and was proven useful in reducing relapses in MS [20]. Natalizumab, the 
VLA-4 antibody, was developed utilizing the knowledge of molecular signatures that T-
cells use to adhere to endothelial cells and transmigrate into target tissue. It was tested 
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and shown effective in suppressing EAE, and later on proven useful in treating MS [53]. 
Although the unfortunate side effect of developing progressive multifocal 
leukoencephalopathy (PML) in some patients, a fatal disease caused by JC virus, led to 
its temporary withdrawal [53], the benefits it provided eventually lead to its return to the 
market. From this lesson, we also learned about the potential consequences of attempting 
to shut down the immune system. Fingolimod, a first-in-class oral drug that utilizes the 
inhibition of T-cell trafficking, downregulates sphingosine-1-phosphate receptor 1 
(S1PR1) and prevented T-cells from exiting the secondary lymphoid organs, was shown 
to suppress EAE and proven to help in RRMS [54]. 
Although studies using EAE have greatly advanced our knowledge in 
autoimmunity, the main criticism about EAE as an MS model is its limited value in 
understanding MS etiology. EAE pathogenesis shares similarities with MS, namely the 
perivascular cell infiltration, autoimmune inflammation, demyelination, gliosis, and the 
sparing of neuronal cell bodies [55]. The knowledge of pathogenesis has led to 
successful treatments. However, the knowledge of causation is required for an effective 
cure. While EAE is purely autoimmune-mediated and can be abolished by blocking 
essential immune pathways [48, 49], it remains to be proven that MS is also purely 
autoimmune-mediated for reasons aforementioned. MS is partially genetic and likely 
occurs in predisposed individuals under certain environmental conditions. Several 
viruses, e.g., human herpesvirus 6 and Epstein-Barr virus, were shown to be potential 
candidates as infectious agents [4]. If MS is indeed caused by infectious agents that lead 
to autoimmunity via molecular mimicry and/or bystander activation, then therapies 
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developed from EAE will not be helpful to prevent MS progression in the long term. 
Although EAE shares features with MS, they also have clear differences. For example, 
inflammation in EAE is primarily driven by CD4+ T-cells, whereas CD8+ T-cells are 
found in greater numbers is MS lesions [56]. Focusing on EAE can thus lead to 
negligence in the contribution of certain cell types that are important in MS. Due to the 
fundamental differences between EAE and MS, it is not surprising that most promising 
treatments tested in EAE fail in treating MS [57]. Because of these shortcomings, 
researchers should bear in mind the applicability when conducting research in EAE. 
EAE is still a useful model for understanding mechanisms of autoimmunity and cell 
trafficking, which are the main focuses of this study. In relating EAE studies to MS, one 
should always evaluate the relevance of the molecule or gene of interest to MS, and 
consider also using other models, such as TMEV, that can recapitulate different aspects 
of MS. 
 
1.3 Myeloid Cells 
1.3.1 Myeloid Lineage Cells of the Immune System 
Hematopoiesis occurs at different sites during different developmental states, 
starting from the yolk sac as early as E7.5 in mice, to the aorta-gonad mesonephros 
region, fetal liver, and eventually the bone marrow after birth [58]. Hematopoiesis at 
different stages features production of different cell lineages. For example, during 
primitive hematopoiesis, which occurs from E7.5 in mice, the erythro-myeloid 
progenitors (EMPs) in the yolk sac give rise to tissue-resident macrophages including 
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the Kupffer cells in the liver [59], Langerhans cells in the epidermis [59, 60], alveolar 
macrophages in the lung [61, 62], intestinal macrophages [63], and microglia in the CNS 
[64-67]. In addition, the EMPs from the yolk sac also contributes to development of fetal 
red blood cells, monocytes, and granulocytes [59]. During definitive hematopoiesis, 
hematopoietic stem cells (HSCs) in the bone marrow first differentiate into more 
committed progenitors for the myeloid lineage and the lymphoid lineage according to 
the classical model [68]. The lymphoid lineage gives rise to B-cells, T-cells, and natural 
killer cells. The myeloid lineage gives rise to erythrocytes, megakaryocytes, 
granulocytes, monocytes, and dendritic cells. Interestingly, the HSC-derived cells 
replace the fetal erythrocytes, granulocytes, monocytes, and intestinal macrophages [63], 
but not certain populations such as the Kupffer cells, Langerhans cells, and microglia 
[59]. These populations primarily maintain their yolk sac origin. The granulocytes, 
monocytes, macrophages, and dendritic cells are often grouped together and collectively 
referred to as the myeloid cells.  
As reviewed by Kawamoto and Minato [69] and Zhu, Yamane [39], myeloid 
cells in the immune system are essential for the host’s innate immune functions. Myeloid 
cells respond to chemoattractants and can gather at the injury or infection sites. Myeloid 
cells express an array of pathogen recognition receptors (PRRs) such as Toll-like 
receptors that recognize pathogen associated molecular patterns (PAMPs) and initiate 
innate immune responses. For example, Toll-like receptor 4 recognizes 
lipopolysaccharide (LPS), a component in the cell wall of gram-negative bacteria, and 
triggers the macrophages to develop a proinflammatory phenotype, called the M1 
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phenotype. M1 macrophages secrete molecules such as tumor necrosis factor α (TNFα) 
and nitric oxide (NO) to combat the pathogens. Professional phagocytes such as 
macrophages and neutrophils also destroy the pathogens by phagocytosing them and 
fusing the phagosomes with lysosomes, thereby breaking them down. While myeloid 
cells have various receptors for phagocytosis, their phagocytic activity can be enhanced 
by the complement system and immunoglobulin receptors. Macrophages and dendritic 
cells then process the broken-down pathogens and present their antigens on the MHC 
Class II molecules on the cell surface that can be recognized by the helper T-cells. 
Myeloid cells also produce various cytokines to instruct the type of T-cell 
differentiation. The interaction between the antigens presented on MHC Class II by the 
dendritic cells and the T-cell receptor on T-cells, along with two other signals known as 
co-stimulation and cytokine expression, induce activation and differentiation of T-cells 
and development of adaptive immune response, which then in turn enhance the functions 
of the innate immune system. 
1.3.2 Roles of Myeloid Cells in MS and EAE 
Accumulation of dendritic cells and macrophages as well as microglial activation 
have been observed in MS lesions [70-72], suggesting the involvement of myeloid cells 
in MS pathology. Although the specific role of myeloid cells in MS is still unclear, HLA 
Class II molecules are not only the strongest genetic factor [4], analysis in MS patient 
peripheral blood mononuclear cells (PBMCs) also showed increased HLA Class II 
expression [73]. Therefore, myeloid cells may be involved in MS through their role in 
antigen presentation, presumably causing autoimmunity. Consistent with these findings, 
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APCs from cervical lymph nodes of MS patients have been found presenting brain 
derived antigens [74]. In addition to antigen presentation, proinflammatory cytokines 
such as TNFα were found to be up-regulated in MS patient PBMCs [73], and nitric oxide 
synthase (NOS) was found in MS lesion areas [75]. Therefore, myeloid cells likely cause 
damage in MS through their innate immune functions. 
While the importance of myeloid cells in MS is difficult to prove, they have been 
shown to be essential in development of EAE. Indeed, depleting macrophages with 
either HSV-TK or clodronate liposome abolishes EAE [76, 77]. Since EAE is mediated 
by CD4+ helper T-cells, myeloid cells are necessary for EAE due to their role to 
differentiate CD4+ T-cells into TH1 and TH17 subsets and subsequently re-activate them. 
Consistent with this, dendritic cells were shown to require the expression of MHC Class 
II molecules for developing adoptive transfer EAE in mice [78]. Furthermore, two-
photon microscopy revealed direct interactions between T-cells and antigen presenting 
cells at leptomeninges during EAE [79]. Similar observations have been made using 
time-lapsed microscopy on isolated meninges from EAE mice [45]. Macrophages are 
also important in their function to break down the extracellular matrix in order to gain 
entry to the CNS, as double knockout of matrix metalloproteinase (MMP)-2 and MMP-9 
suppresses EAE symptoms [52]. These studies indicate that myeloid cells play an 
indispensable role in EAE. 
1.3.3 Myeloid Cells and Leukocyte Trafficking into the CNS 
During an inflammation, myeloid cells in the immune system secrete chemokines 
such as CCL2, CCL3, and CCL5 to attract leukocytes by chemical gradient. Myeloid 
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cells also stimulate the endothelial cells of the blood vessel to express ICAM-1 and 
VCAM-1, which are recognized by their respective ligands, LFA-1 and VLA-4, 
expressed by T-cells, and cause the T-cells in the bloodstream to halt and pass through 
the endothelial cell layer into the inflammatory site [80]. 
The transmigration of immune cells into the CNS parenchyma during a CNS 
injury or infection is complicated by the fact that access to CNS involves passing the 
blood-brain barrier (BBB) [52]. Across the cerebrovascular endothelial cell (CVEC) 
layer, there is a basal membrane and associated with it is the glial limitan. This basal 
membrane contains various extracellular matrix (ECM) proteins such as laminin and 
fibronectin. The glial limitan consists of astrocyte end feet anchored to the basal 
membrane, as well as pericytes. The space between the CVEC layer and the glial limitan 
is called perivascular space. Depleting monocytes/macrophages with clodronate 
liposome causes T cells to accumulate in the perivascular space, but not into the CNS 
parenchyma during EAE, thus preventing disease progression [76]. This suggests that 
myeloid cells have a role in assisting T cells to transmigrate through the parenchymal 
basal membrane. 
Toft-Hansen et al. [81] found that leukocytes spontaneously accumulate in the 
perivascular space of CCL2 overexpressing mice, and treatment with pertussis toxin 
(PT) causes the cells to infiltrate into the parenchyma. The authors also found that using 
a broad-spectrum matrix metalloproteinase (MMP) inhibitor prevents this infiltration. 
Using an in vitro model, Abraham et al. [82] showed that T cell migration through 
Matrigel-coated transwell inserts induced by chemokines CCL5 and CXCL10 was 
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inhibited by MMP inhibitors. These results suggest a dependence of MMPs to break 
down the ECM to allow efficient leukocyte infiltration. 
As reviewed in Yong et al. [83], MMP-2, 7, 9, and 12 are elevated in MS and are 
correlated with increased gadolinium enhancement in MRI scans, which is an indication 
of disruption in BBB integrity. Toft-Hansen et al. [51] examined all members of the 
metalloproteinase family and found an increase of MMP-2, 8, 9, 10, 12, as well as 
TIMP-1 during EAE, with macrophages being the major source and only a few 
exceptions, making the study of MMPs in EAE highly relevant to MS. Agrawal et al. 
[52] found that MMP-2 and MMP-9 targets β-dystroglycan, which anchors astrocyte 
endfeet to the parenchymal basal membrane through high affinity binding to laminin. 
These authors also found that double knockout of MMP-2 and MMP-9 inhibits EAE. As 
the major cellular source of MMP-2 and MMP-9, macrophages thus contribute to the 
breakdown of glial limitan during EAE, allowing leukocytes to infiltrate into the CNS 
parenchyma. While these findings indicate the importance of myeloid MMPs in EAE, it 
is to be noted that as Yong, Zabad [83] pointed out, single MMP deficiency does not 
necessarily confer resistance to EAE. MMP-9 KO mice are less susceptible to EAE only 
in younger age (3-4w). MMP-2 KO and MMP-12 KO in fact caused more severe EAE 
due to compensatory increases in other MMPs. Therefore, studying and interpretation of 
MMPs’ role in EAE have to proceed with caution. 
While some studies suggest that leukocytes can accumulate in the perivascular 
cuff but myeloid cells are required to break through the blood brain barrier basal 
membrane, Agrawal et al. [52] reported that they did not observe accumulation of 
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leukocytes in the perivascular cuff in their MMP-2 and MMP-9 double knockout mice. 
Thus, it is possible that myeloid cells are not only needed for breaking through the 
parenchymal basal membrane, but also for transmigrating across the cerebrovascular 
endothelial layer as well. In support of this, Kivisakk and others [44] discovered that 
memory T-cells carry out immune surveillance at the subarachnoid space. The 
interaction between antigen presenting cells and T-cells at the leptomeninges has been 
observed [45, 79]. Moreover, the CNS lymphatic system has recently been discovered 
[47]. Together with the common observation that EAE pathology begins at the 
meninges, these suggest a possible mechanism by which EAE develops: Autoimmune T-
cells polarized in the peripheral immune organs move to the CSF for daily surveillance, 
where they meet local macrophages and dendritic cells that are presenting antigens 
drained and collected from the interstitial fluid in CNS. The interaction of MOG 
presented on MHC II and MOG specific T-cells triggers T-cell reactivation and thus 
causing meningitis. The local inflammation caused tissue damage and activated adjacent 
macrophages and microglia, which then secreted proinflammatory cytokines and 
chemokines and MMPs, causing disruption of BBB and infiltration of leukocytes into 
the CNS parenchyma. Therefore, myeloid cells are important in assisting leukocyte 
transmigration due to their role in presenting antigens at the leptomeninges for immune 
surveillance as well as the secretion of proteases such as MMPs to break down the blood 
brain barrier. 
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1.4 Signal Transducer and Activator of Transcription (STAT)-3 
1.4.1 Overview of STAT3 
STAT3 is a 89 kDa protein of the STATs family, which contains 7 proteins, 
STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, and STAT6, and are involved in 
transducing cytokines and growth factors and control of gene expression. STAT3 exists 
in two forms: full-length and abundantly expressed STAT3α, and a truncated STAT3β 
formed by alternative splicing. STAT3α contains an N-terminal domain, a coiled coil 
domain, a DNA binding domain, a linker domain, an SH2 domain, and a transactivation 
domain. STAT3β lacks the transactivation domain and can competitively inhibit the 
transcriptional factor functions of STAT3α [84], but has also been shown to have its own 
functions [85].  
As illustrated in Figure 2, Certain receptors of cytokines or growth factors, e.g., 
the IL-6 receptor family, form dimer or oligomer complex upon ligand binding, and 
recruit and phosphorylate Janus kinases (JAKs). The resulted complex provides docking 
site for the SH2 domain on STAT3 and can phosphorylate STAT3 at its tyrosine 705 
residue near the C-terminus [86]. STAT3 phosphorylated at tyrosine 705 (pSTAT3-
Y705) forms homodimers via the SH2 domains, and are translocated into the nucleus 
with the help of members of the importin protein family [87]. STAT3 then forms 
complex with other transcriptional factors and coactivators or repressors to regulate gene 
expression. While tyrosine phosphorylation enables the transcriptional functions of 
STAT3, STAT3 is also phosphorylated at serine 727 by JNK and p38 MAPK, resulting 
in enhanced and sustained transcriptional functions [88]. In addition, serine 
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phosphorylation in STAT3 can aid in respiratory functions in mitochondria, as STAT3 
deficiency reduces the activities in the electron transport chain [89]. Other than the 
tyrosine and serine phosphorylation, unphosphorylated STAT3 has also been shown to 
function independently of the phosphorylated dimers. For example, unphosphorylated 
STAT3 interacts with NF-κB and drives transcription of genes such as CCL5 [90]. 
STAT3 signaling is negatively regulated by suppressor of cytokine signaling (SOCS)-3, 
which can be induced by IL-6 signaling as a negative feedback. SOCS3 acts by 
ubiquitination of phospho-JAKs and phospho-STATs or by binding to specific cytokine 
receptor and JAK complexes [91]. Although SOCS3 can inhibit multiple JAKs, e.g., 
JAK1, JAK2, and TYK2, and multiple STATs, e.g., STAT1, STAT3, and STAT4 [91], 
its inhibiting activity is limited to specific receptor and JAK complexes rather than 
individual molecules. For example, SOCS3 can inhibit IL-6 induced STAT3 signaling 
by binding to gp130 and JAK2 [91], but not IL-10 induced STAT3 signaling, which is 
via IL-10 receptor complex and JAK1 [92]. 
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Figure 2. STAT3 signaling. 
 
 
Generally, STAT3 functions in regulating genes that are involved in cell cycle 
and cell survival. STAT3 is essential for transducing leukemia inhibitory factor (LIF)-
induced embryonic stem cell self-renewal, as it targets transcription factors such as Klf4 
and Klf5 and many others that, knockdown of which leads to reduced self-renewal [93]. 
Using a fusion protein consisting of STAT3 and the estrogen receptor that can be 
activated by 4-hydroxytamoxifen, it was shown that STAT3 signal can maintain 
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embryonic stem cell self-renewal in the absence of LIF [94]. Because STAT3 is 
important in the maintenance of embryonic stem cells, its universal knockout leads to 
embryonic death in mice at E6.5 – 7.5 [95]. STAT3 transduces the signal from IL-6 and 
gp130 receptor and activates the transcription of c-Myc gene, a gene that promotes cell 
cycle [96]. In the CNS, STAT3 has been shown to be activated during IL-15-induced 
proliferation of neural stem cells in the subventricular zone [97]. STAT3 has also been 
shown to be involved in ciliary neurotrophic factor (CNTF)-induced as well as IL-6- and 
LIF-induced astrogliogenesis [98, 99]. STAT3 inhibits apoptosis by activating Bcl-2 
transcription, thereby mediating IL-6-induced maintenance of human HSC self-renewal 
[100]. Blocking of STAT3 reduced expression of Bcl-xL, another anti-apoptotic gene, in 
a human cancer cell line and induced apoptosis, suggesting the importance of STAT3 in 
inhibition of apoptosis [101]. In addition, IL-6 induces miR-21 expression and 
contributes to anti-apoptotic functions in myeloma cells, and this pathway is STAT3-
dependent [102]. In the CNS, STAT3 has been shown to signal anti-apoptotic functions 
of IL-9 in neonatal cortical neurons by down regulation of Bax [103]. Because STAT3 is 
involved in cell survival and is constitutively activated in cancer cells, many cancer 
studies have focused on STAT3 as a therapeutic target. This also includes glioma, in 
which STAT3 is aberrantly activated [104]. 
In addition to regulation of gene expression involved in cell cycle, studies have 
found that STAT3 also has many other functions particularly in the CNS. For example, 
leptin regulates energy balance and is mediated through STAT3 signaling in the 
hypothalamus [105]. Disrupting STAT3 in neurons thus causes obesity and diabetes 
 23 
 
[106]. In the oligodendrocytes, STAT3 has been shown to promote oligodendrocyte 
survival and differentiation and is required for efficient remyelination after lysolecithin 
injection [107]. STAT3 is also shown to be involved in synaptic plasticity. Inhibiting 
STAT3 with AG490 impairs spatial memory, suggesting its role in synaptic plasticity 
and implications in pathogenesis of Alzheimer’s disease [108]. NMDA receptor-
dependent long term depression was shown to be blocked by AG490 [109].  
1.4.2 STAT3 and Neutrophils 
Neutrophils are the first responders during an infection or inflammation. 
Neutrophil infiltration has been observed during the onset phase of EAE, correlating to 
demyelination at the lesion sites [110]. Granulocyte-colony stimulating factor (G-CSF) 
signals through STAT3 and is a key cytokine in neutrophil maturation and migration. G-
CSFR mutation causes severe neutropenia and accumulation of immature myeloid 
progenitors, but expression of a constitutively active STAT3 rescues the phenotype 
[111], suggesting an important role of STAT3 in neutrophil functions. However, 
conditional deletion of STAT3 in hematopoietic progenitors using Mx-Cre/Stat3fl/fl 
resulted in higher number of neutrophils, which exhibited normal respiratory burst, 
phagocytosis, and bacteria killing capabilities [112], similar to the neutrophilia observed 
in hematopoietic lineage specific SOCS3 deficient mice [113]. Interestingly, mice 
deficient of SOCS3 in myeloid cells develop an atypical and non-resolving form of EAE 
characterized by enhanced recruitment of neutrophils into the cerebellum [114]. It is 
possible that the conditional deletion of STAT3, causing a prolonged and enhanced 
proinflammatory response in the absence of IL-10 signaling, compensates for the 
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impaired G-CSF signaling in neutrophil functions. The role of STAT3 in neutrophil 
functions thus requires further investigation. 
1.4.3 STAT3 and CD4+ T-Cells 
CD4+ T-cells are part of the adaptive immune system and can secrete various 
cytokines to help other cells’ functions. Naïve CD4+ T-cells can be differentiated into 
different effector subsets depending on immune context and cytokine crosstalk. For 
example, IL-12 signals through STAT4 and drives the production of IFNγ, which acts in 
an autocrine fashion and signals through STAT1, driving the expression of T-bet and 
TH1 differentiation [115]. In the case of TH17, TGFβ signaling first induces the 
production of RORγt. IL-6 signals through STAT3 to produce IL-21. IL-21 acts in an 
autocrine fashion and drives IL-23 receptor expression through a STAT3- and RORγt-
dependent pathway. The autocrine loop of IL-21 ensures sustained activation of STAT3, 
and IL-23 is important in the maintenance of TH17 phenotype. These signals together 
lead to fully committed IL-17 producing TH17 cells [116, 117]. Without the signal 
starting from IL-6, TGFβ-driven transcriptional factor Foxp3 suppresses the activity of 
RORγt and shifts the differentiation towards regulatory T-cells (Tregs). Since both TH1 
and TH17 cells are essential in the induction of EAE [48, 49], and STAT3 mediates TH17 
differentiation [116, 117], selective deletion of STAT3 in CD4+ T-cells completely 
prevents the development of EAE [118], suggesting the pathogenic function of STAT3 
in CD4+ T-cells in autoimmune demyelination diseases. However, the importance of 
STAT in innate immune cells such as myeloid cells in the context of MS and EAE have 
not been directly investigated and was investigated in this study. 
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1.4.4 STAT3 in Myeloid Cells and MS 
Genome-wide association studies identified Stat3 as a risk factor in MS [12, 
119], suggesting its role in MS disease pathology. Elevated pSTAT3 has been detected 
in CD4+ T-cells, CD8+ T-cells, and CD14+ monocytes in peripheral blood mononuclear 
cells (PBMCs) from relapsing MS patients [120]. While the functions of STAT3 in 
CD4+ T-cells and its importance in EAE have been well documented, its functions in 
myeloid cells in the context of MS and EAE pathologies are not as clearly understood. 
CD14+ monocytes in PBMCs from relapsing MS patients showed elevated pSTAT3 
compared to remitting patients and healthy individuals [120]. pSTAT3 was found in 
macrophages and microglia in post-mortem CNS tissue from MS patients [121]. 
Collectively, these suggest that myeloid STAT3 may also be involved in MS.  
STAT3 has a nonredundant role in signaling IL-10 anti-inflammatory response 
(AIR) in myeloid cells [122]. IL-10 signals through the IL-10 receptor complex, which 
contains two IL-10R1 and two IL-10R2 chains and are expressed by most leukocytes. 
The receptor complex signals through JAK1 and STAT3, which participates in AIR by 
turning on “AIR factor” genes that inhibit the production of proinflammatory mediators. 
These include but are not exclusive to Bcl3 and Etv3, both of which inhibit NF-κB, Nfil3 
to inhibit IL-12 production, and Zfp36 that degrades TNFα mRNA [122]. IL-10 
deficiency in mice results in exacerbated EAE [123]. Loss of STAT3 in myeloid cells 
over time induces chronic enterocolitis [124] due to enhanced proinflammatory 
responses in the absence of AIR. Therefore, loss of STAT3, causing an enhanced and 
prolonged immune response, perceivably could be detrimental to autoimmune diseases 
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such as EAE. On the other hand, STAT3 mediates IL-6 signaling, which is involved in 
inflammatory events such as acute phase responses [125]. IL-6/STAT3 signaling in 
dendritic cells also causes proinflammatory responses and drives production of TNFα 
and several chemokines [126]. The authors also found that whether STAT3 participates 
in proinflammation or anti-inflammation depends on the length of activation. Because 
SOCS3 targets the IL-6R complex but not IL-10R complex, IL-6 signaling results in 
transient activation of STAT3 and proinflammatory responses, and IL-10 signaling 
results in prolonged activation of STAT3 and AIR. However, it is still unclear which 
pathway will dominate in the case of conditional deletion or pharmaceutical inhibition. 
As aforementioned, conditional deletion of SOCS3 in myeloid cells causes exacerbated 
EAE [127], supporting a hypothesis that inhibiting STAT3 may be beneficial. 
Interestingly, double knockout of MMP-2 and MMP-9 confers resistance to EAE [52], 
and both MMP-2 and MMP-9 were shown to be at least in part regulated by STAT3 
[128, 129], indicating that myeloid STAT3 may have a role in transmigration and its 
inhibition may be beneficial in treating autoimmune diseases. In this study, we 
investigated the role of STAT3 in autoimmunity during EAE by generating mice with 
targeted ablation of STAT3 in the myeloid cells.  
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2. DELETION OF STAT3 IN PERIPHERAL MYELOID CELLS RENDERS C57BL/6 
MICE LESS SUSCEPTIBLE TO MOG35-55-INDUCED EAE 
 
2.1 Introduction 
Multiple sclerosis (MS) is a debilitating disease characterized by demyelination 
and neurodegeneration in the central nervous system (CNS) [130]. MS lesions in the 
CNS are multifocal and heterogeneous in nature and can be characterized into several 
groups based on the distribution of immune cells and other criteria [9]. Specifically, the 
lesions are characterized into groups that feature autoimmune encephalomyelitis and 
groups that feature oligodendrocyte dystrophy[9]. The heterogeneity in both its 
symptoms and pathologies suggest it may involve multiple different mechanisms. 
Currently, MS is believed to occur in genetically predisposed individuals under specific 
environmental cues and involves autoimmune mechanisms [4, 131, 132].  
Myeloid cells are an indispensable part of the innate immune system. 
Accumulating dendritic cells and macrophage/microglial activation have been observed 
in MS lesions [70-72]. The number of infiltrating monocytes/macrophages usually 
outnumbers T-cells, suggesting the importance of myeloid cells in MS pathology. 
Moreover, not only certain HLA Class II molecules are the strongest genetic factor in 
MS [4], analysis in MS PBMCs also showed increased HLA Class II expression during 
acute relapse [73]. Therefore, myeloid cells are likely involved in MS pathogenesis 
through their role in antigen presentation. Consistent with these findings, APCs from 
cervical lymph nodes (LNs) of MS patients have been found to be presenting brain 
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derived antigens [74]. In addition, pro-inflammatory cytokines such as TNFα was found 
to be up-regulated in MS patient PBMCs [73], and NOS was found in MS lesion areas 
[75]. Therefore, myeloid cells may cause damage in MS through their innate immune 
functions. 
Experimental autoimmune encephalomyelitis (EAE) is an autoimmune-driven 
animal model of MS. Macrophages have been shown to be critical in the development 
and progression of EAE, as depleting monocytes/macrophages abolishes EAE [76, 77]. 
Since EAE is mediated by CD4+ helper T-cells [49, 50, 133], myeloid cells are necessary 
for EAE due to their role in differentiating CD4+ T-cells into TH1 and TH17 subsets and 
subsequently re-activating them. Consistent with this, the expression of MHC Class II 
molecules on DCs has been shown to be necessary for the development of adoptive 
transfer EAE in mice [78]. Furthermore, antigen-presenting cells (APCs) were found to 
directly interact with and activate T-cells during EAE in the leptomeninges and in newly 
developing CNS lesions [45, 79]. Myeloid cells are also important in their function to 
break down the extracellular matrix and increase BBB permeability, as double ablation 
of MMP-2 and MMP-9 suppressed EAE [52]. 
STAT3 is an 89 kDa protein of the STATs family and transduces signals of many 
cytokines including LIF, IL-6, G-CSF, IL-2, IL-7, IL-21, IL-10, and more [117]. 
Genome-wide association studies identified Stat3 as a risk factor in MS [12, 119], 
suggesting its role in MS disease pathology. Elevated pSTAT3 has been detected in 
CD4+ T-cells, CD8+ T-cells, and CD14+ monocytes in PBMCs from relapsing MS 
patients compared to remitting patients and healthy subjects [120]. pSTAT3 was found 
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in macrophages and microglia in post-mortem CNS tissue from MS patients [121]. 
These studies suggest that STAT3 signaling in myeloid cells may be involved in the 
pathogenesis of MS.  
STAT3 has a nonredundant role in signaling IL-10 anti-inflammatory responses 
(AIR) in monocytes/macrophages [122]. Il10 deficiency causes exacerbated EAE [123]. 
Loss of Stat3 in myeloid cells over time induces chronic enterocolitis [124] due to 
enhanced proinflammatory responses in the absence of AIR. Therefore, loss of STAT3 
could aggravate autoimmune diseases such as EAE. On the other hand, STAT3 mediates 
IL-6 signaling, which involves inflammatory events such as acute phase responses [125]. 
Furthermore, conditional deletion of SOCS3 in myeloid cells, an inhibitor of STAT3, 
causes exacerbated EAE [127], suggesting that inhibiting STAT3 may suppress EAE.  
To study the role of myeloid STAT3 signaling in EAE, we generated conditional 
STAT3 mutant mice by crossbreeding LysMcre and Stat3fl/fl mice and subjected them to 
MOG35-55-induced active EAE. We found that LysMcre/Stat3
fl/fl mice are significantly 
more resistant to actively induced EAE but are susceptible to passive EAE induced by 
transfer of encephalitogenic T-cells. We also found that loss of STAT3 in myeloid cells 
decreased the surface expression of antigen presenting and co-stimulatory molecules and 
impaired antigen-specific activation of CD4+ helper T-cells in ex vivo co-cultures. Our 
study highlights the importance of myeloid STAT3 in autoimmune T-cell generation, 
and our data suggest that STAT3 may be a potential therapeutic target for autoimmune 
diseases. 
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2.2 Materials and Methods 
2.2.1 Human Tissue and Sample Preparation 
Preparation of CNS tissue from human MS and control subjects was described 
previously [134]. Briefly, frozen brain tissues from MS patients with clinical diagnosis 
and confirmed pathologies and from control subjects were obtained from the Rocky 
Mountain MS Center (Englewood, CO) and the Human Brain and Spinal Fluid Resource 
Center (Los Angeles, CA). The tissues were divided with one half for homogenization 
and the other half for immunohistochemistry. 
2.2.2 Animals 
Stat3fl/fl mice contain two loxP sites that flank exon 22 of Stat3 gene [135] and 
were a generous gift from Dr. Shizuo Akira (Hyogo College of Medicine, Nishinomiya, 
Japan). Upon arrival, the STAT3fl/fl mice were backcrossed to C57BL/6 mice for 8 
generations. LysMcre mice express Cre recombinase driven by the Lyz2 promoter and 
were described previously [136]. Cx3cr1creER mice express an enhanced yellow 
fluorescent protein (EYFP) and a Cre recombinase linked to a mutated estrogen receptor 
under the control of endogenous Cx3cr1 promoter [137]. Conditional knockout mice 
were generated by crossbreeding Stat3fl/fl mice to either LysMcre or Cx3cr1creER mice. 
B6.129P2-Lyz2tm1(cre)Ifo/J mice (LysMcre), B6.129P2(Cg)-Cx3cr1tm2.1(cre/ERT2)Litt/WganJ 
mice (Cx3cr1creER), B6.SJL-Ptprca Pepcb/BoyJ mice (C57BL/6 CD45.1), C57BL/6-
Tg(Tcra2D2,Tcrb2D2)1Kuch/J mice (2D2), B6;129S6-Gt(ROSA)26Sortm14(CAG-
tdTomato)Hze/J mice (rosa26-Ai14) were obtained from Jackson Laboratory (Bar Harbor, 
ME). Mice were under husbandry and bred in the animal facility in Texas A&M 
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University Comparative Medicine Program. All animal studies were approved by the 
Institutional Animal Care and Use Committee at Texas A&M University. 
2.2.3 Administration of Tamoxifen 
Tamoxifen (T5648, Sigma-Aldrich) was administered in either 5-week old 
Cx3cr1-creER/Stat3fl/fl mice. Tamoxifen was first dissolved in corn oil (C8267, Sigma-
Aldrich) at 40 mg/ml by incubating while shaking at 37°C for 30 min followed by pulse 
sonication. Each mouse at age of 5 weeks received 2 doses of 8 mg tamoxifen (in 200 µl 
corn oil) by oral gavage, 48 hr apart. 
2.2.4 Induction of MOG35-55-induced Active EAE 
MOG-induced EAE was carried out as previously described [138] with 
modifications. Briefly, 20 ml of Incomplete Freund’s adjuvant (263910, Difco, Detroit, 
MI) was mixed with 100 mg heat killed Mycobacterium tuberculosis H37 RA (231141, 
Difco) and vortexed for 5 min to make complete Freund’s adjuvant (CFA). MOG35-55 
peptide (AS-60130-10, Anaspec Inc., Fremont, CA) was reconstituted in sterile PBS at 2 
mg/ml. CFA was emulsified with MOG35-55 at a 1:1 volume ratio by short bursts of 
sonication using  Microson Ultrasonic Cell Disrupter XL2000 (Misonix, Farmingdale, 
NY) and concurrent addition of MOG35-55 drop-wise for 20 min, followed by vigorous 
vortexing for 45 min. Mice were anesthetized with i.p. injection of 100 mg/kg body 
weight ketamine and 10 mg/kg body weight xylazine, and followed by s.c. injection of 
200 µl MOG35-55-containing CFA, containing 200 µg MOG35-55 peptide and 500 µg M. 
tuberculosis) and i.p. injection of 400 ng pertussis toxin (#180, List Biological 
Laboratories, Inc., Campbell, CA) in 100 µl PBS. The second dose of 500 ng pertussis 
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toxin was administered 48 hrs later. Mice were weighted and clinical symptoms were 
assessed on a daily basis. Clinical symptoms were scored according to the following 
criteria: 1, tail paralysis; 2, hind limb paresis; 3, unilateral hind limb paralysis; 4, 
bilateral hind limb paralysis; 5, moribund or death. 
2.2.5 Passive EAE Induction by Adoptive Transfer 
Passive induction of EAE was previously described [50] with modifications. 
Briefly, donor C57BL/6 mice were immunized for MOG35-55 using the same procedure 
as in active EAE induction. Pertussis toxin was not administered. Ten days after 
immunization, draining LNs were isolated from donor mice and single cell suspension 
was prepared from draining LNs and cultured at 5.0 × 107 cells in 10 ml complete RPMI 
1640 medium (11875-085; Life Technologies), containing 10% FBS, 4 mM L-
glutamine, 1 mM sodium pyruvate (P2256; Sigma-Aldrich), 50 μM β-mercaptoethanol 
(M7154; Sigma-Aldrich), and 100 IU/ml Penicillin and 100 μg/ml Streptomycin (15140; 
Life Technologies), in 100 mm petri dishes in the presence of 20 μg/ml MOG35-55 for 4 
days. After 4 days of culture, cells were rinsed off and washed with original RPMI 1640 
medium, and resuspended in original RPMI 1640 medium at RT at the density of 1.0 - 
2.0 × 107 cells/ml. Cells were aliquoted 5 ml into several 15 ml conical tubes. One 
volume of Lympholyte M (CL5031; Cedarlane, Burlington, NC) was layered using a 
Pasteur pipette to the bottom of tubes. The tubes were then centrifuged at 1,000 × g at 
RT for 20 min with the brake set to 0. Cells at the interphase were collected using a 
Pasteur pipette, washed twice with sterile PBS, centrifuged at 600 × g at 4°C for 10 min, 
and resuspended at the density of 1.5 × 107 cells in 200 μl sterile PBS. Cells (1.5 – 2.0 × 
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107) were injected r.o. into recipient mice that were sublethally irradiated by 400 rad a 
day before cell transfer. 400 ng pertussis toxin was injected i.p. on the same day of cell 
injection and then 48 hrs after. Clinical symptoms were assessed on a daily basis 
following the same criteria as for active EAE. 
2.2.6 Bone Marrow Chimera 
Mouse bone marrow was isolated as previously described [139]. Briefly, donor 
mice (5-8 weeks) were euthanized with isoflurane (5260-04-05, Abbott Laboratories, 
North Chicago, IL) followed by cervical dislocation. Skin around the hind limbs was 
removed, and the hind limbs were isolated with scissors without the femur bones 
damaged. Muscle tissue around the femur and tibia bones was removed. The bone heads 
were trimmed with scissors to have bone marrow slightly exposed. The bone marrow 
was ejected from the bone using a 23G needle and a 3 ml syringe loaded with PBS 
containing 2% FBS and was made into single cell suspension by passing through the 
needle twice and filtering through a 70 um cell strainer. The red blood cells were lysed 
with red blood cell lysing buffer (R7757, Sigma-Aldrich, St. Louis, MO) for 5min on 
ice, and then washed and reconstituted in sterile PBS at the density of 3.33 × 107 
cells/ml.  
Recipient mice of age 5-6 weeks were constrained in perforated 50 ml conical 
tubes and subject to 10-Gray X-ray irradiation. Within the same day, the mice were 
anesthetized with isoflurane and injected 5.0 × 106 bone marrow cells r.o. in 150 µl PBS. 
Animals were housed in autoclaved cages and supplied with irradiated food and drinking 
water with 1.25% antibiotics (sulfamethoxazole and trimethoprim; 50383, Hi-Tech 
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Pharmacal Co. Inc., Amityville, NY) for 2 weeks before being switched back to regular 
housing. At 6 weeks post transplantation, active EAE was induced as described above. 
2.2.7 Tissue Collection 
The mice at desired age or EAE stage were deeply anesthetized with ketamine 
and xylazine. Blood was collected by cardiac puncture and mixed 2:1 with 10 usp/ml 
heparin solution (H3393, Sigma-Aldrich) for preparation of single cell suspension or 
placed in empty Eppendorf tubes for preparation of serum. The mice were then perfused 
through the left ventricle with 20 ml of PBS. The spleen and draining lymph nodes 
(inguinal, axillary, and cervical) were removed and placed in Eppendorf tubes with PBS 
containing 2% FBS on ice. For histological analysis of the CNS, the brain and spine 
were removed and fixed in 4% paraformaldehyde (PFA; P6148, Sigma-Aldrich) in PBS 
overnight at 4°C. For analysis of CNS infiltrating leukocytes, the spinal cord was ejected 
from the spine with a 10 ml syringe attached to a 20G cannula and filled with ice-cold 
PBS. For analysis of cytokine mRNA expression in the CNS, the brain and ejected 
spinal cord were flash frozen with liquid nitrogen and stored at -80°C until use. 
2.2.8 Isolation of CNS Infiltrating Leukocytes 
Brain and spinal cord from EAE mice were disrupted with scissors and digested 
in 5 ml of Stempro Accutase (A11105-01; Life Technologies, Carlsbad, CA) for 30 min 
at 37°C. The enzyme activity of Accutase was then blocked by addition of 2 ml 100% 
FBS. Tissues were then filtered through a 70 μm cell strainer with the help of a 3 ml 
syringe plunger to make single cell suspension. Cells were centrifuged and resuspended 
in 35% Percoll (P4937; Sigma-Aldrich) in PBS. 70% Percoll was slowly added to the 
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bottom with a Pasteur pipette attached to a rubber bulb. The tubes were then centrifuged 
at 2,000 × g for 20 min at 18°C with the brake set to 0. Cells in the interphase between 
35% and 70% Percoll were harvested with a Pasteur pipette, washed and resuspended in 
complete RPMI 1640 medium (11875-085; Life Technologies), containing 10% FBS, 4 
mM L-glutamine, 1 mM sodium pyruvate (P2256; Sigma-Aldrich), 50 μM β-
mercaptoethanol (M7154; Sigma-Aldrich), and 100 IU/ml penicillin and 100 μg/ml 
streptomycin (15140; Life Technologies). 
2.2.9 Preparation of Single Cell Suspensions from Spleen, Lymph Nodes, and Blood 
Spleen and draining lymph nodes from EAE mice were disrupted with a 3 ml 
syringe plunger and passed through a 70 μm cell strainer. Splenocytes were centrifuged 
and resuspended in 3 ml of RBC lysis buffer (R7757, Sigma-Aldrich) and incubated at 
room temperature for 2 min, then washed in complete RPMI 1640 medium. 
200 μl of blood collected from the mice were mixed with 100 μl heparin (10 
usp/ml; H3393; Sigma-Aldrich). 1 ml of RBC lysis buffer was added, and the samples 
were incubated at room temperature for 15 min. Cells were then centrifuged and 
resuspended in PBS containing 2% FBS. If no clear white pellet was observed after 
centrifugation, the lysis procedure was repeated once. 
2.2.10 Magnetic selection of CD11b+ and CD4+ cells 
Single cell suspension of splenocytes prepared from mice was resuspended in BD 
iMAG buffer (552362, BD Biosciences, San Jose, CA) at the density of 2.0 × 107 
cells/ml in a 15 ml conical tube and incubated with 20 μg/ml α-CD11b-biotin (40 μl per 
ml; 13-0112, eBioscience, San Diego, CA) or 10 μg/ml α-CD4-biotin (20 μl per ml; 13-
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0042, eBioscience) for 15 min on ice. The cells were then washed twice and resuspended 
in iMAG buffer at the density of 4.0 × 107 cells/ml. Streptavidin (557812, BD 
Biosciences) was added (10 μl per 1.0 × 107 cells) and incubated at 8°C for 30 min. The 
volume was then brought to 2.0 × 107 cells/ml and the tube was placed onto a cell 
separation magnet (#552311; BD Biosciences) and incubated at room temperature for 8 
min. The negative portion was removed while the tube was still on the magnet, and the 
positive portion was resuspended in iMAG buffer at 2.0 × 107 cells/ml. The separation 
was repeated two more times with 4 min incubation at room temperature each time. 
After the last separation, the positive portion was resuspended in complete RPMI 1640 
medium. 
2.2.11 Preparation of Cell Cultures 
Primary Mixed Glia and Microglia. Neonatal mouse pups of age postnatal day 0-
3 (P0-3) were ice anesthetized and then decapitated. Under a dissecting microscope, the 
brains were isolated, and the meninges were carefully peeled off using two pairs of 
tweezers. Tissue was disrupted with a razor blade and digested in HBSS containing 
0.01% trypsin (T8253, Sigma-Aldrich) and 10 µg/ml DNase (D5025, Sigma-Aldrich) at 
37°C for 10 min, and passed through a 70-µm cell strainer to make single cell 
suspension. Cells were washed, resuspended and cultured in poly-D-lysine (P0899, 
Sigma-Aldrich) coated plates or flasks with complete DMEM medium containing 10% 
FBS, 4mM L-glutamine (G8540, Sigma-Aldrich), 1mM sodium pyruvate (P2256, 
Sigma-Aldrich), 100 IU/ml penicillin and 100 µg/ml streptomycin (15140, Life 
Technologies), for 10-14 days before experiments were conducted. Media was 
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replenished every other day. Microglia mono-culture was obtained by shaking the mixed 
glia flasks (25-cm2 or 75-cm2) at 200 rpm for 1 hr and collecting the supernatant as 
previously described [140]. 
BMDM. The preparation of BMDMs was previously described [139]. Briefly, 
L929 cells (ATCC#CCL-1; a generous gift from Dr. Beiyan Zhou) were cultured at the 
density of 5.0 x 105 cells in 15 ml complete DMEM medium per 75-cm2 culture flask. At 
div 5, the culture was centrifuged at 400 × g, and the conditioned medium were collected 
and stored in -20°C until use. Bone marrow cells isolated as described above were 
resuspended in IMDM medium (Hyclone, #SH30228.01) containing 15% L929-
conditioned medium and 10% FBS at the density of 1.0 x 106 cells/ml. 1.0 x 107 cells per 
100-mm petri dish were cultured for 7 days. The medium was replenished at div 3. At 
div 7, the cells were incubated in HBSS containing 5 mM EDTA at 4°C for 40 min, then 
harvested by flushing with a P1000 Eppendorf pipette. Mature BMDMs were washed 
and resuspended in IMDM medium containing 10% FBS for experiments. BMDM 
maturity was analyze with CD11b and F4/80 staining and flow cytometry. 
2.2.12 Western Blotting 
To determine the functional effect of STAT3 deletion, BMDMs from Stat3fl/fl and 
LysMcre/Stat3fl/fl mice were stimulated with 10 ng/ml rmIL-6 (1830-SR, R&D Systems, 
Minneapolis, MN) in IMDM medium containing 10% FBS for 30 min at 37°C. Cells 
were then lysed with ice-cold lysing buffer, which contains 20 mM Tris-HCl, 150 mM 
NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% triton-X100, 10 mM Na4P2O7, 10 mM NaF, 
1.0% PIC (P8340, Sigma-Aldrich), 100 mM Na3VO4, and 100 mM PMSF, and was 
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sonicated in short bursts for several seconds using a Microson ultrasonic cell disrupter at 
level 2. Protein in the supernatant was collected after centrifugation at 16,000 × g for 15 
min at 4°C. Protein level was quantitated using a DC Protein Assay kit (5000116, Bio-
Rad, Hercules, CA), and the concentration was equalized by adding ddH2O. After 
denaturing and linearizing by boiling and adding 2% SDS and 1% β-mercaptoethanol, 
proteins were separated in an 8% polyacrylamide gel by SDS-PAGE, and transferred to 
a PVDF membrane. The membrane was blocked with 5% BSA for 1 hr at room 
temperature, and probed with α-STAT3 (9132, Cell Signaling Technology Inc., Danvers, 
MA) and α-pSTAT3(Y705) (9145, Cell Signaling Technology Inc.) antibodies at 4°C for 
overnight. The membrane was then washed with TBS with 0.1% Tween (P7949, Sigma 
Aldrich) three times for 5 min each, and incubated with α-rabbit IgG-HRP antibody 
(115-035-062, Jackson ImmunoResearch, West Grove, PA) for 1 hr at room temperature 
and was developed with SuperSignal West Pico substrate (34080, Thermo Scientific, 
Rockford, IL). Images were acquired on a Bio-Rad Chemidoc XRS System (Bio-Rad, 
Hercules, CA). Densitometric data were obtained using Quantity One software (Bio-
Rad, Hercules, CA). 
2.2.13 RNA Isolation and Quantitative RT-PCR 
For tissue, flash frozen spinal cord from EAE mice were thawed, incubated in 1 
ml Tri Reagent (T9424, Sigma Aldrich), homogenized in a tissue homogenizer, and 
transferred to a 1.5-ml Eppendorf tube. For cell culture, the supernatant was first 
collected at the end of stimulation. Next, 1 ml Tri Reagent was added into the well, 
pipette-flushed several times and transferred to a 1.5-ml Eppendorf tube. The sample 
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tubes were incubated for 5 min at room temperature. 200 µl of chloroform (#4440, 
Macron Fine Chemicals) was added, and the tubes were vigorously hand-shaken for 15 
sec and vortexed for another 15 sec. The tubes were centrifuged at 12,000 × g for 15 min 
at 4°C. 500 µl of liquid in the clear upper phase was collected and added with 500 µl 
isopropanol. After sitting for 10 min at room temperature, the tubes were centrifuged at 
12,000 × g for 30 min in 4°C. The supernatant was removed and the pellets were 
resuspended in 1 ml 75% ethanol, and centrifuged at 7,500 × g for 5 min at 4°C. The 
supernatant was then removed again, and the pellets were dissolved by adding 100 µl 
nuclease free H2O (#10336503, Fisher Scientific, Fair Lawn, NJ) and incubating at 56°C 
for 10 min. The isolated RNA was quantitated using a NanoDrop 1000 
Spectrophotometer (Thermo Scientific) and stored at -80°C until use. 
500 ng RNA samples were treated with 0.1 UI/µl DNase I (#18068, Invitrogen, 
Carlsbad, CA) for 15 min at room temperature to remove DNA contamination. 2.5 mM 
EDTA was added and samples were incubated for 10 min at 56°C to inactivate DNase 
activity. Samples were then reverse transcribed to cDNA in a reaction mixture of 5 mM 
magnesium chloride, 0.25 mM dATP, 0.25 mM dTTP, 0.25 mM dCTP, 0.25 mM dGTP, 
0.75 U/ml reverse transcriptase (M510F, Promega, Madison, WI), 25 µg/ml random 
primers (C118A, Promega), and 1 U/ml RNase inhibitor (N251B, Promega), and 
incubated in the following thermal cycling parameters: 25°C 10 min, 42°C 15 min, 95°C 
5 min. DNA contamination was checked by reverse transcribing samples without reverse 
transcriptase and amplifying β-actin with PCR. 10 ng cDNA was amplified with 
quantitative PCR in a reaction mixture of 1x SYBR Green PCR Master Mix (#4309155, 
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applied biosystems, UK) and 1 µM forward and reverse primers in the following thermal 
cycling parameters: 95°C 10 min, [95°C 15 sec, 60°C 1 min] × 40 cycles. Changes of the 
expression levels relative to β-actin were calculated using the formula: 2(-ΔΔCT). The 
primer pairs used were listed in Table 1. 
 
Table 1. Primer sets for PCR. 
 
 
2.2.14 Enzyme Linked Immunosorbant Assay (ELISA) 
Levels of secreted cytokines in cell culture supernatants were analyzed with 
Ready-SET-Go!®  ELISA kits (mouse IFNγ, #88-7314; mouse IL-17A, #88-7371; 
mouse TNFα, #88-7324; mouse IL-1β, #88-7013; mouse CCL2, #88-7391; mouse IL-6, 
#88-7064; mouse IL-12p70, #88-7121; eBioscience, San Diego, CA) following the 
manufacturer’s instructions. 
2.2.15 Flow Cytometry 
1.0-5.0 × 105 cells were resuspended in 50 µl PBS containing 2% FBS. 
Nonspecific binding of Fc receptors was blocked by incubating with 5 µg/ml α-ms 
Gene  Forward Primer Reverse Primer 
β-actin AGACTTCGAGCAGGAGATGG CAACGTCACACTTCATGATGG 
Tnfα TGTCCCTTTCACTCACTGGC CATCTTTTGGGGGAGTGCCT 
Il1β CGACAAAATACCTGTGGCCT CGACAAAATACCTGTGGCCT 
Ifnγ AAGACTGTGATTGCGGGGTT GCACCAGGTGTCAAGTCTCT 
Trem GGCTGAGGTCCTGCAGAAAG GCACCCTCGAAACTCGATGA 
Cd206 AAGGCATGCGTTGCACATAC ATTCTGCTCGATGTTGCCCA 
Ccl2 GGCTCAGCCAGATGCAGTTA GCTGCTGGTGATCCTCTTGT 
Ccl3 CCGGAAGATTCCACGCCAAT GTCTCTTTGGAGTCAGCGCA 
Ccl5 GCCAGCTTGGGGATGCCACTC CAGAGCCTCGGAGCAGCTGAG 
Il6 TGGTGACAACCACGGCCTTCC AGCCTCCGACTTGTGAAGTGGT 
Il12p40 CGCAGCAAAGCAAGATGTGT CGTGTCACAGGTGAGGTTCA 
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CD16/32 antibody (#14-0161, eBioscience) for 10 min on ice. Cells were then stained 
with fluorochrome-conjugated antibodies (α-ms CD11b FITC, #11-0112; α-ms Ly-6G 
PE, #61-9668; α-ms F4/80 APC, #17-4801; α-ms CD8 FITC, #11-0081; α-ms CD19 PE, 
#12-0193; α-ms CD4 APC, #17-0041; α-ms CD11c PE, #12-0114; α-ms Ly-6C APC, 
#17-5932; α-ms/rt CD40 FITC, #11-0402; α-ms CD80 PE, #12-0801; α-ms CD86 APC, 
#17-0862; α-ms MHC II APC, #17-5321; α-ms CD45 PE-Cy5.5, #35-0451; α-ms 
CD45.1 FITC, #11-0453; α-ms CD45.2 APC, #17-0454; eBioscience) at 1/200 dilution 
in a total volume of 100 µl for 20 min on ice in dark, and subsequently washed and 
resuspended in PBS with 2% FBS. Flow cytometric data were acquired on a BD Accuri 
C6 flow cytometer (BD Biosciences, San Jose, CA). Color compensation, gating, and 
data analysis were performed on the proprietary software from the manufacturer. 
2.2.16 Multiplex Immunoassay 
Levels of multiple cytokines in the myeloid and T-cell co-culture experiment 
were analyzed with ProcartaPlex Mix&Match Mouse 15-plex kit (eBioscience, EPX150-
25074-801) following the manufacturer’s instructions. 
2.2.17 Immunohistochemistry/Immunocytochemistry 
Brain and vertebral column were isolated from normal and EAE mice and fixed 
in 4% PFA in PBS at 4°C overnight. The next day, the spinal cord was carefully isolated 
from the spine using scissors and forceps, and fixed in 4% PFA again for an additional 4 
hr. The tissues were then cryoprotected with 30% sucrose in PBS for roughly two days 
until sunk. Tissues were embedded in Tissue-Tek O.C.T. Compound (#4583, Sakura 
Finetek USA, Inc., Torrance, CA) and frozen sectioned into 10 μm sections on Leica 
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CM1950 cryostat (Leica, Nusslock, Germany). Sections were adhered onto Superfrost 
Plus Microscope Slides (Fisher Scientific, Waltham, MA) and stored at -20°C until use. 
Slides were thawed and dried for 30 min to 1 hr at 37°C prior to staining. For 
visualization of myelin structure and integrity, the sections were stained with Oil-Red-O 
solution by overnight incubation in 0.5% (w/v) Oil-Red-O (00625, Sigma-Aldrich) 
dissolved in propylene glycol (S264, Poly Scientific R&D Corp, Bay Shore, NY) at 
room temperature. For immunofluorescence, appropriate regions of the slides were 
marked with an ImmEdge hydrophobic barrier pen (Vector Lab, Inc. Burlingame, CA) to 
separate different sections. The sections were rinsed in PBS for 5 min to remove O.C.T. 
Compound. Sections were blocked for unspecific binding and permeabilized with PBS 
containing 5% goat serum and 0.3% Triton X-100 (T9284, Sigma Aldrich) for 1 hr at 
room temperature, and incubated with rabbit α-Iba-1 (1:400; #019-19741, Wako, 
Richmond, VA), rat α-CD68 (1:400; MCA1957, BioRAD, Hercules, CA), rabbit α-
GFAP (1:100; 18-0063, Invitrogen), tomatolectin (B-1175, Vector Labs), rat α-ms 
ICAM-1 (1:100; 14-0542-81, eBioscience), rat α-ms PECAM-1 (1:50; 553370, BD 
Biosciences), rat α-ms CD3 (1:100, 14-0032, eBioscience), rat α-ms CD4 (1:100, 14-
0042, eBioscience), rabbit α-pSTAT3(Y705) (1:100; #9145, Cell Signaling), ms α-
human CD11b (ab63317, AbCam) diluted in PBS containing 5% goat serum and 0.1% 
Triton X-100 at 4°C overnight. The next day, tissue sections were washed in PBS three 
times for 5 min each, and incubated with goat α-rb IgG conjugated to Alexa Fluor 488 
(A11034, Invitrogen, Eugene, OR) or goat α-ms IgG conjugated to Alexa Fluor 488 
(A11029, Invitrogen, Eugene, OR) diluted 1:1000 in PBS containing 5% goat serum and 
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0.1% Triton X-100 for 1 hr at room temperature in dark. Cell nuclei were stained with 
Hoechst 33342 (Invitrogen) at 1:1000 dilution in PBS for 1 min. Human MS CNS tissue 
was also stained with Sudan black by incubation in 0.3% (w/v) Sudan black (Sigma-
Aldrich) dissolved in 70% (v/v) ethanol at room temperature for 2 min to decrease 
autofluorescence in the lipid. Images were acquired with an Olympus IX71 microscope 
(Olympus, Tokyo, Japan) with constant settings across different sections/samples. Post-
processing (image merging and background removal) was performed in a uniform 
fashion in Adobe Photoshop software.  
2.2.18 Data Analysis 
When appropriate, differences between two groups were analyzed with two-
tailed Student’s t test. Differences between more than two groups were analyzed with 
multivariate analysis of variance followed by Bonferroni’s post hoc test. The cumulative 
EAE scores of Stat3fl/fl and LysMcre/Stat3fl/fl mice were analyzed with Wilcoxon rank-
sum test. The rate of EAE onset of Stat3fl/fl and LysMcre/Stat3fl/fl mice was analyzed with 
Pearson chi-square test and Fisher’s exact test. Differences were considered statistically 
significant if p < 0.05.  
 
2.3 Results 
2.3.1 STAT3 Is Activated in Myeloid Cells in Human MS CNS 
We first investigated whether STAT3 is activated in myeloid cells in MS lesions. 
As shown in Figure 3A, the level of pSTAT3 (Y705) and total STAT3 were evaluated 
by Western blotting analysis of postmortem brain tissue from MS patients and control 
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subjects (Table 2). pSTAT3 (Y705) was increased by ~4.9 fold, and total STAT3 was 
increased by ~2.3 fold in MS patients compared to control individuals (Figure 3B). Next, 
we examined whether STAT3 is activated in specifically infiltrating myeloid cells in MS 
lesions with immunofluorescence. As shown in Figure 3C, in actively demyelinating 
lesions, we found multiple pSTAT3+ cells, some of which co-localized with CD11b+ 
cells. In contrast, we did not find any pSTAT3 (Y705) signal in control patients. These 
data indicate that STAT3 is activated in subsets of myeloid cells in active MS lesion and 
suggest that STAT3 may be involved in the pathogenesis of MS. 
 
Table 2. Summary of pathological information on MS patients and control subjects. 
Diagnosis ID Age/Sex Clinical Diagnosis/Cause of Death 
Control 
#C-1 86/F Clinical diagnosis of MS 
#C-2 74/M Progressive Supranuclear Palsy 
#C-3 19/M Gun shot (abdomen) 
#C-4 15/M Accidental hanging 
#C-5 31/M Anemia, pencytopenia 
#C-6 29/M Motor cycle accident 
MS 
#MS-1 69/M MS 
#MS-2 44/M MS (chronic progressive), aspiration pneumonia, 
grand mal seizure with status epilepticus 
#MS-3 40/F MS (progressive, severe, unrelenting for 10 yrs) 
#MS-4 63/F MS, Sleep Apnea, Chronic urinary tract infection, 
respiratory failure, Hypertension 
#MS-5 52/F MS (secondary progressive) 
#MS-6 51/F MS (secondary progressive) 
#MS-7 75/F MS, hypertension, kidney stone surgery, Goiter 
surgery, Hypothyroidism, Migraine,Chronic 
uninary tract infection 
#MS-8 54/F MS (relapse-remitting) 
 
  
 45 
 
 
Figure 3. Increased STAT3 phosphorylation in active MS lesions. A, Protein lysates from non-
neurological controls (n = 6) and MS patients (n = 8) were immunoblotted with antibodies against 
pSTAT3 (Y705) and total STAT3. Each lane represents one individual. B, Level of pSTAT3 and total 
STAT3 was quantitated with densitometry. Data represent mean ± SEM. *p < 0.05, **p < 0.01.  C, 
Representative pictures of MS patient CNS tissue. Tissue was stained with α-CD11b (green), α-pSTAT3 
(Y705) (red), Hoechst (blue), and Sudan black. Scale bar, 50 µm. Scale bar, 10 µm (insert). 
 
 
2.3.2 STAT3 Is Activated in MOG35-55-induced EAE in C57BL/6 Mice 
Next, we investigated whether STAT3 is activated during MOG35-55-induced 
EAE in C57BL/6 mice. Using markers for myeloid cells, astrocytes, and T-cells, we 
examined the activation of STAT3 in SC lumbar cord sections from EAE mice 14 dpi 
(Figure 4). We found that pSTAT3 was colocalized to CD68+ (Figure 4A), tomatolectin+ 
(Figure 4D), and CD11b+ (Figure 4E) myeloid cells at or near inflammatory locations in 
the parenchyma during active EAE (indicated by white arrows), whereas only a few 
pSTAT3+ cells colocalized to GFAP+ astrocytes (Figure 4B) or CD4+ T-cells (Figure 
4F). In contrast to EAE, pSTAT3 signal was absent in normal naïve spinal cord (Figure 
4C). Together, these data suggest that activation of STAT3 in myeloid cells may 
contribute to the pathogenesis of EAE. 
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Figure 4. STAT3 is activated in the myeloid cells during EAE. Spinal cord sections from EAE 
C57BL/6 mice at 14 dpi (A, B, D-F) or naïve C57BL/6 mice (C) were analyzed with 
immunofluorescence. Shown are representative pictures of the mid ventral region. Arrows indicate double 
labeled cells. Inserts show higher magnification of double labeled cells. A, B, pSTAT3 was colocalized to 
CD68+ activated microglia/macrophages but only to a few GFAP+ astrocytes. C, pSTAT3 signal was 
absent in naïve spinal cord. D, Some pSTAT3+ cells were also tomatolectin positive, which labels blood 
vessels and microglia/macrophages. E, Some pSTAT3+ cells were also colocalized to CD11b+ myeloid 
cells. F, pSTAT3 had only a few colocalizations with CD4 in the parenchyma. Some double labeled cells 
were found in the leptomeninges. Scale bar, 50 µm. 
 
 
2.3.3 STAT3 Is Selectively Inactivated in Myeloid Cells in LysMcre/Stat3fl/fl Mice 
To study the function of STAT3 in myeloid cells, we utilized the loxP/Cre 
system and crossed LysMcre line with Stat3fl/fl line to obtain the conditional knockout. 
As shown in Figure 5A, Cre recombinase expressed under the control of the lysozyme M 
promoter causes recombination at the two loxP sites, resulting in the deletion of exon 22 
in Stat3 gene, which contains the Tyrosine 705 residue of which phosphorylation is 
critical for STAT3 activation and transcription activity. To confirm that the targeted 
A
D E F
B C
CD4 pSTAT3CD11b pSTAT3TL pSTAT3
GFAP pSTAT3 naiveGFAP pSTAT3CD68 pSTAT3
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sequence is indeed deleted in myeloid cells upon Cre recombination, we designed 
primers to flank the entire deleted sequence. The deleted band (Δdel) of ~550 bp was 
amplified using the DNA from FACS-sorted CD11b+ splenocytes from LysMcre/Stat3fl/fl 
mice, whereas the flox band of ~3500 bp was amplified from Stat3fl/fl mice (Figure 5B). 
These results demonstrated that Stat3 exon 22 was indeed excised in the myeloid cells of 
LysMcre/Stat3fl/fl mice.  
We next compared the extent of Tyrosine 705 phosphorylation upon brief IL-6 
stimulation in cultured BMDMs prepared from LysMcre/Stat3fl/fl and littermate Stat3fl/fl 
control mice. Although the total protein level of STAT3 was not significantly decreased 
in the LysMcre/Stat3fl/fl BMDMs since only exon 22 was deleted, STAT3 
phosphorylation was significantly impaired in the LysMcre/Stat3fl/fl BMDMs after 30 
min stimulation of IL-6 (Figure 5C, D). These data demonstrated that STAT3 activation 
is functionally impaired in the LysMcre/Stat3fl/fl cells. 
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Figure 5. STAT3 was selectively inactivated in myeloid cells in LysMcre/Stat3fl/fl mice.  A, Exon 22 
was flanked by two loxP sites and excised by Cre recombination. F and R, primers designed to flank the 
entire deleted sequence. Forward-CCTCTACCCCGACATTCCCAAGG, reverse-
CACACAAGCCATCAAACTCTGGTCTC. B, DNA was purified from FACS-sorted CD11b+ cells from 
the spleen from LysMcre/Stat3fl/fl mice. The flox band (~3500 bp) and the deleted band (Δdel; ~550 bp) 
was amplified with PCR using the primer in A. C, D, BMDMs from adult LysMcre/Stat3fl/fl (n = 3) and 
Stat3fl/fl (n = 3) mice were stimulated with 10 ng/ml rmIL-6 for 30 min. Cell lysates were immunoblotted 
with antibodies against pSTAT3 (Y705) and total STAT3 and quantitated with densitometry in D. Data 
represent mean ± SEM. ***p < 0.005. E, The reporter line rosa26-Ai14 expresses RFP upon Cre 
recombination. F, Expression of reporter activity in the spleen and CNS in 9-month old LysMcre/rosa26-
Ai14 mice (n = 3) was analyzed with flow cytometry. Granulocytes, CD11b+Gr-1+; Ly6Chi monocytes, 
CD11b+Ly6Chi; Macrophages, CD11b+Ly6Clo; Dendritic cells, CD11b+CD11c+; T-cells, CD3+; B-cells, 
CD19+; Microglia, CD11b+CD45int. Data represent Mean ± SEM.  G-J, Expression of reporter activity in 
the cerebral cortex (G), hippocampus (H), spinal cord (I), and colon (J) from naïve adult LysMcre/rosa26-
Ai14 mice of ~2 months of age were analyzed with immunostaining of Iba-1. Representative pictures were 
shown. Arrows indicate the location of inserts. K-N, Spinal cord sections from LysMcre/rosa26-Ai14 EAE 
mice were stained with α-Iba-1 (K, M) and α-pSTAT3 (L, N). Representative pictures were shown. M, 
Higher magnification of the boxed region in K. N, Higher magnification of the boxed region in L. Arrows 
indicate the location of inserts. Scale bar (G-L), 50 µm. Scale bar (M, N), 25 µm. 
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After establishing the efficacy of Stat3 targeting and functional inactivation, we 
then asked where LysM-driven Cre recombination occurs in vivo, and more importantly 
what cell types undergo LysM-driven Stat3 inactivation during EAE. We thus crossed 
LysMcre mice with the reporter line rosa26-Ai14 to determine the efficiency of Cre 
recombinase activity in various cell types in the splenocytes and CNS mononuclear cells 
with flow cytometry. Granulocytes showed the highest tdTomato expression and are at 
87.5% (Figure 5E). Monocytes and dendritic cells also showed abundant expression at 
61.1% and 56.7%, respectively, whereas only 36.5% microglia expressed tdTomato 
(Figure 5E). Consistent with the flow cytometric data, there were sparing Iba-
1+tdTomato+ cells in the cerebral cortex (Figure 5H), hippocampus (Figure 5H), and 
spinal cord (Figure 5I), whereas relatively more abundant colocalizations could be found 
in the colon (Figure 5J). We also noticed distinct Iba-1-tdTomato+ cells in the CA3 
region of the hippocampus (Figure 5H) as well as in the gray matter of the spinal cord 
(Figure 5I), which suggests that LysM-driven Cre recombination may also occur in 
specific subsets of neurons.  In contrast to naïve SC, Iba-1+tdTomato+ cells were much 
more abundant in the inflamed region in EAE spinal cord (Figure 5K, M). STAT3 was 
activated in tdTomato+ cells during EAE (Figure 5L, N), but not in the naïve. Together, 
these data indicate that the animal model is sufficient in reducing activation of STAT3. 
2.3.4 LysMcre/Stat3fl/fl Mice Are Significantly Less Susceptible to MOG35-55-induced 
EAE 
GWAS studies identified that Stat3 is one of the MS susceptibility genes [12, 
119]. Together with our finding that STAT3 is activated in myeloid cells in MS lesions 
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(Figure 3), this suggests that myeloid STAT3 activation may be involved in generation 
or regulation of autoimmune processes. To investigate this, we subjected Stat3fl/fl and 
LysMcre/Stat3fl/fl mice to MOG35-55-induced EAE. While most Stat3
fl/fl mice (81.8%) 
developed EAE two weeks after immunization, only 5.56% of LysMcre/Stat3fl/fl mice 
showed EAE clinical symptoms (Figure 6A, C). The onset of EAE symptoms often 
accompanies weight loss, and consistent with their decreased susceptibility, 
LysMcre/Stat3fl/fl mice did not exhibit as much weight loss as Stat3fl/fl mice (Figure 6B). 
In addition to the absence of classic EAE symptoms, there was no sign of demyelination 
in the lumbar cord of LysMcre/Stat3fl/fl mice (Figure 6D). When analyzed 2 weeks after 
immunization, LysMcre/Stat3fl/fl mice contained significantly less CNS infiltrating 
leukocytes including macrophages/monocytes and lymphocytes compared to Stat3fl/fl 
mice (Figure 6E, F). At 21 dpi, the spinal cord from LysMcre/Stat3fl/fl mice contained 
few activated macrophages (Figure 6G), and microglia mostly remained in a ramified 
resting state (Figure 6H). In agreement with this observation, LysMcre/Stat3fl/fl mice also 
expressed significantly less proinflammatory mediators in the spinal cord than Stat3fl/fl 
mice (Figure 6I). Together, these data demonstrated that loss of STAT3 signaling in 
myeloid cells suppressed leukocyte infiltration and neuroinflammation in MOG-
immunized mice. 
To investigate whether myeloid STAT3 deletion affects the transmigrating 
capability of the cells, we next investigated whether the suppressed leukocyte CNS 
infiltration in the LysMcre/Stat3fl/fl mice is associated with decreased expression of 
adhesion molecules and/or better structural integrity of the BBB (Figure 7). ICAM-1 
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mRNA was significantly increased in the immunized Stat3fl/fl mouse spinal cord, but 
LysMcre/Stat3fl/fl was not significantly different from those of naïve mice (Figure 7A). 
VCAM-1 showed a trend of increase only in the Stat3fl/fl (Figure 7A). Consistent with 
the mRNA data, immunostaining revealed that ICAM-1 was drastically increased in the 
vasculature of immunized Stat3fl/fl particularly in regions with infiltration of Iba-1+ 
macrophages/microglia during the peak stage of EAE (Figure 7B). In contrast, we only 
observed ICAM-1 staining in the leptomeninges but not within the spinal cord of the 
LysMcre/Stat3fl/fl mice (Figure 7B). We visualized the BBB area with PECAM and 
GFAP immunostaining and found many cells at the paravascular cuff in the Stat3fl/fl at 
peak stage of EAE, but not in the LysMcre/Stat3fl/fl (Figure 7C). Together, these data 
provide strong evidence that myeloid STAT3 signaling is essential in the development of 
MOG35-55-induced EAE. 
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Figure 6. LysMcre/Stat3fl/fl mice are resistant to actively induced EAE. A-C, Stat3fl/fl (n = 44) and 
LysMcre/Stat3fl/fl mice (n = 36) were immunized for MOG35-55-induced EAE and evaluated on daily basis 
using the scoring criteria described in the methods section. A, Table of onset rate. B, Clinical scores up to 
21 dpi. C, Percentage weight change. D, Myelin structure in the spinal cord sections from 21 dpi mice was 
analyzed with Oil-Red-O staining. Representative pictures were shown. E, F, CNS infiltrating leukocytes 
were isolated from Stat3fl/fl (n = 4) and LysMcre/Stat3fl/fl EAE mice (n = 4) at 14 dpi and analyzed with 
flow cytometry. Microglia, CD11b+CD45int; Macrophages, CD11b+CD45hi. G, H, Spinal cord sections 
from mice at 21 dpi were cryosectioned and stained with Hoechst (blue) and antibodies for Iba-1 (red) and 
CD68 (green). Representative pictures were shown. Scale bar (G), 200 µm. Scale bar (H), 50 µm. I, RNA 
was isolated from spinal cord of Stat3fl/fl (n = 5) and LysMcre/Stat3fl/fl mice (n = 5) at 14 dpi and analyzed 
with quantitative RT-PCR. Data represent fold expression compared to naïve group. Data represent mean 
± SEM.   *p < 0.05, **p < 0.01, ***p < 0.005. 
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Figure 7. Expression of cell adhesion molecules during EAE. Active EAE was induced in the Stat3fl/fl 
and LysMcre/Stat3fl/fl mice. A, RNA was isolated form spinal cord from immunized mice at 14 dpi 
(Stat3fl/fl, n = 4; LysMcre/Stat3fl/fl, n = 3) and from naïve C57BL/6 mice (n = 3). Expression level of Icam1 
and Vcam1 mRNA was analyzed by quantitative RT-PCR. Data represent mean ± SEM. **p < 0.01. B, C, 
Spinal cord from mice at 14 dpi were cryosectioned and stained with Hoechst (blue) and antibodies for 
Iba-1 (green) and ICAM-1 (red, B) or PECAM (red, C). Representative pictures were shown. Lower 
panels are the magnified view of the red boxes in the upper panels. Scale bar, 50 µm. 
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2.3.5 Peripheral TH1 and TH17 Responses Are Reduced in LysMcre/Stat3
fl/fl Mice during 
Pre-clinical and Onset Stages of EAE 
Since EAE is an autoimmune-driven disease, the resistance to EAE may be 
attributable to diminished adaptive immune response in the peripheral immune system. 
Therefore, we evaluated the kinetics of peripheral immune response by performing CD4+ 
T-cell cytokine recall experiments at different stages of EAE. During the pre-clinical and 
onset stages of EAE, LysMcre/Stat3fl/fl splenocytes secreted significantly less IFNγ 
compared to Stat3fl/fl (Figure 8A). Although a significant difference in IL-17A was not 
found, there was a consistent trend of decreased IL-17A secretion in the 
LysMcre/Stat3fl/fl up until the peak stage (Figure 8B). We also found a significant 
decrease in GM-CSF (Figure 8C) and many cytokines and chemokines, namely TNFα, 
IL-1β, IL-6, IL-12p70, IL-18, IL-23, IP-10 and CCL5 (Figure 9) during the disease 
onset. During the post peak stage of EAE, none of the three cytokines showed significant 
differences between Stat3fl/fl and LysMcre/Stat3fl/fl (Figure 8A-C), nor did most other 
cytokines we tested (Figure 9).  
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Figure 8. Peripheral MOG-specific T-cell responses were impaired during pre-clinical and onset of 
EAE. EAE was induced in Stat3fl/fl and LysMcre/Stat3fl/fl mice. Splenocytes were isolated at four different 
stages of disease and cultured at 5.0 × 105 cells per well in 96-well U-shaped plates in complete RPMI 
medium in the absence or presence of 30 μg/ml MOG35-55 for 3 d. Cytokine secretion into the supernatant 
was determined with ELISA. Pre-clinical, 12 dpi, Stat3fl/fl, n = 6; LysMcre/Stat3fl/fl, n = 5. Onset, 19 dpi, 
Stat3fl/fl, n = 6; LysMcre/Stat3fl/fl, n = 4. Peak, 28 dpi, Stat3fl/fl, n = 5; LysMcre/Stat3fl/fl, n = 2. Post-peak, 49 
dpi, Stat3fl/fl, n = 3; LysMcre/Stat3fl/fl, n = 2. A, IFNγ. B, IL-17A. C, GM-CSF. Data represent mean ± 
SEM. *p < 0.05, **p < 0.01, ***p < 0.005.  
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Figure 9. Cytokine responses during different stages of EAE development. EAE was induced in 
Stat3fl/fl and LysMcre/Stat3fl/fl mice. Splenocytes were isolated at different stages of disease and cultured at 
5.0 × 105 cells per well in 96-well U-shaped plates in complete RPMI medium in the absence or presence 
of 30 μg/ml MOG35-55 for 3 d. Cytokine secretion into the supernatant was determined using multiplex 
immunoassay. 16 dpi, Stat3fl/fl, n = 4; LysMcre/Stat3fl/fl, n = 3. 19 dpi, Stat3fl/fl, n = 6; LysMcre/Stat3fl/fl, n = 
4. 22 dpi, Stat3fl/fl, n = 4; LysMcre/Stat3fl/fl, n = 4. 28 dpi, Stat3fl/fl, n = 5; LysMcre/Stat3fl/fl, n = 2. 49 dpi, 
Stat3fl/fl, n = 3; LysMcre/Stat3fl/fl, n = 2. Data represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.005. 
 
 
In addition to the levels of secreted cytokines, we also investigated the number of 
activated TH1 and TH17 cells in the spleen during EAE. The number of IFNγ-producing 
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TH1 cells were significantly less in LysMcre/Stat3
fl/fl at the onset stage of EAE as 
compared to Stat3fl/fl control mice (Figure 10A). Interestingly, this pattern was reversed 
during the peak and post peak stages of EAE (Figure 10A), although the differences 
were not statistically significant and the LysMcre/Stat3fl/fl mice did not exhibit any EAE 
clinical symptoms. In contrast to the differences in TH1, there were no significant 
differences for IL-17A-secreting TH17 cells between the genotypes at the onset or peak 
stages of EAE (Figure 10B). To rule out the possibility that the differences in cytokine 
recall may be due to a potential shift in immune cell population in the LysMcre/Stat3fl/fl 
mice, we analyzed cell profile of spleen and blood from mice at different EAE stages 
(Figure 11). During the pre-clinical stage of EAE, there was no differences in any of the 
myeloid cells or lymphocytes we tested between the genotypes (Figure 11A). During the 
onset stage of EAE, we observed a trend towards decreased percentage of myeloid 
populations in the blood as well as decreased percentage of lymphocyte populations in 
the spleen in the LysMcre/Stat3fl/fl mice (Figure 11B). This pattern is, however, not seen 
during the peak stage of EAE (Figure 11C). During the peak stage of EAE, we saw a 
trend towards increased neutrophil and monocyte population in the blood (Figure 11C). 
However, none of these differences were statistically significant. Last, we found no 
major differences in the cell profile at post-peak stage of EAE (Figure 11D). Therefore, 
the differences in cytokine responses between the genotypes are not likely to be due to a 
shift in major leukocyte populations. Taken together, these data indicate that loss of 
STAT3 signaling in myeloid cells results in decreased TH1 responses primarily in pre-
clinical and early peak stages of EAE as well as a trend in decreased TH17 responses. 
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These data suggest that activation of STAT3 in myeloid lineage cells is required for 
generating antigen-specific TH1 and TH17 responses, and that the impaired T-cell 
responses in LysMcre/Stat3fl/fl mice render them less susceptible to EAE. 
 
 
Figure 10. LysMcre/Stat3fl/fl mice’ secondary lymphoid organs contained lower number of MOG-
specific TH1 cells at EAE onset. Active EAE was induced in Stat3fl/fl and LysMcre/Stat3fl/fl mice. 
Splenocytes were isolated at three different stages of disease and cultured in the presence of 100 µg/ml 
MOG35-55 in complete RPMI medium for 24 h. Cytokine secretion was blocked by Brefeldin A for the last 
5 h. The cells were then fixed and stained with α-CD4, α-IFNγ, α-IL-17A, and α-GM-CSF, and analyzed 
with flow cytometry. A, TH1 cells. B, TH17 cells. Onset, 19 dpi, Stat3fl/fl, n = 6; LysMcre/Stat3fl/fl, n = 4. 
Peak, 22 dpi, Stat3fl/fl, n = 4; LysMcre/Stat3fl/fl, n = 4. Post-peak, 49 dpi, Stat3fl/fl, n = 3; LysMcre/Stat3fl/fl, n 
= 2. Data represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.005. 
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Figure 11. No major cell profile difference was found during EAE. Active EAE was induced in 
Stat3fl/fl and LysMcre/Stat3fl/fl mice. Splenocytes and blood were isolated at four different stages of 
disease and stained with antibodies for cell surface markers. Neutrophils, CD11b+Ly6G+; Dendritic cells, 
CD11b+CD11c+; Ly6Chi monocytes, CD11b+Ly6Chi; Ly6Clo monocytes, CD11b+Ly6Clo; CD4+ T-cells, 
CD4+; CD8+ T-cells, CD8+; B-cells, CD19+. A, Pre-clinical, 12 dpi, Stat3fl/fl, n = 6; LysMcre/Stat3fl/fl, n = 
5. B, Onset, 19 dpi, Stat3fl/fl, n = 6; LysMcre/Stat3fl/fl, n = 4. C, Peak, 28 dpi, Stat3fl/fl, n = 5; 
LysMcre/Stat3fl/fl, n = 2. D, Post-peak, 49 dpi, Stat3fl/fl, n = 3; LysMcre/Stat3fl/fl, n = 2. Data represent mean 
± SEM.   
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2.3.6 Stat3 Deletion in Myeloid Cells Impairs Their Capability to Differentiate Naïve 
CD4+ T-Cells ex vivo 
Since certain myeloid cell types such as macrophages and dendritic cells are 
capable of differentiating naïve helper T-cells into effector T-cells, which are important 
in EAE, impairment in such capability may result in decreased T-cell response and 
resistance to EAE. To test this, we took an ex vivo co-culture approach and isolated 
CD11b+ splenocytes from LysMcre/Stat3fl/fl mice 9-10 days after immunizing with 
MOG35-55 and co-cultured the CD11b
+ cells with naïve CD4+ T-cells from 2D2 mice in 
the absence or presence of MOG35-55 peptide (Figure 12A). We first tested the purity of 
magnetic selection (Figure 13). Both CD11b and CD4 positive selection yielded highly 
enriched populations (84.3% and 89.9%, respectively; Figure 13A, B). There were no 
major differences in the cell populations in the isolated CD11b+ cells between the 
genotypes (Figure 13C).  
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Figure 12. CD11b+ myeloid cells from LysMcre/Stat3fl/fl mice exhibit impaired capability to 
differentiate CD4+ T-cells ex vivo. A-D, Stat3fl/fl and LysMcre/Stat3fl/fl mice were immunized with 
MOG35-55, but PT was not administered. After 9-10 days, CD11b+ cells from spleens of immunized Stat3fl/fl 
and LysMcre/Stat3fl/fl mice as well as CD4+ cells from naïve 2D2 mice were isolated with magnetic 
selection. CD11b+ and CD4+ cells were co-cultured at a 2:1 ratio in the presence of 30 µg/ml MOG35-55 for 
2-3 days before the supernatant and cells were harvested and analyzed. Cells from 3 Stat3fl/fl and 3 
LysMcre/Stat3fl/fl mice were pooled and cultured in triplicates.  A, The experimental design was depicted 
in a diagram. B, Number of IFNγ- and IL-17A-producing T-cells at div 2 were analyzed with intracellular 
staining and flow cytometry. Numbers next to red boxes indicate percentage of IFNγ+ or IL-17A+ of total 
CD4+. C, Percentage of total CD4+ cells at div 2 was analyzed with flow cytometry. D, Cytokine secretion 
from the co-culture at div 3 was analyzed with multiplex immunoassay. E, F, 2.0 × 105 CD11b+ cells from 
the immunized mice were stimulated with 10 ng/ml LPS and 10 ng/ml IFNγ for 24 h. E, Expression of 
inflammatory cytokines was analyzed with multiplex immunoassay. F, Cells were stained with antibodies 
against MHC Class II, CD40, CD80, and CD86 and analyzed with flow cytometry. Data represent mean ± 
SEM. *p < 0.05, **p < 0.01, ***p < 0.005. 
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Figure 13. Efficiency and cell profile analysis of magnetic cell selection for the ex vivo co-culture 
experiment. CD11b+ cells from splenocytes of immunized Stat3fl/fl and LysMcre/Stat3fl/fl mice as well as 
CD4+ cells from naïve 2D2 mice were isolated with magnetic cell selection as described in the methods. 
A, B, Efficiency of selection was determined with staining of α-CD11b (A) or α-CD4 (B) and flow 
cytometry. C, Selected cells at div 0 as well as co-cultured cells at div 2 were stained with antibodies for 
various cells markers to investigate cell type differences. 
  
 63 
 
To examine the capacity of CD11b+ myeloid cells in activating and 
differentiating naïve 2D2 helper T-cells, we co-cultured them at ratio of 2:1 (myeloid:T-
cells) for 2-3 days. After 2 days, the co- co-culture of mutant myeloid cells and 2D2 T-
cells contained less total amount of CD4+ T-cells as well as IFNγ-producing and IL-
17A-producing T-cells compared to the co-culture of Stat3fl/fl myeloid cells and 2D2 T-
cells (Figure 12B, C). At div 3, the co-culture of mutant myeloid cells and 2D2 T-cells 
secreted significantly less IFNγ, IL-17A, and GM-CSF than the co-culture of Stat3fl/fl 
myeloid cells and 2D2 T-cells (Figure 12D). We also saw decreased expression of many 
other inflammatory mediators including IL-4, TNFα, IL-1β, IL-6, IL-12, IL-18, IL-23, 
MIP-1a, and RANTES (Figure 14B). When LysMcre/Stat3fl/fl CD11b+ splenocytes were 
cultured alone, we found a small decrease in the secretion of TNFα and IL-1β (Figure 
12E). However, IL-6 and IL-12, the important cytokines for development of TH17 and 
TH1, respectively, were not significantly different (Figure 12E). We also saw decreased 
expression of IL-17A, MIP-1a, and RANTES, but not IL-4, IL-10, IL-18, IL-23, or IP-
10 (Figure 14B). Interestingly, MCP-1 was increased in LysMcre/Stat3fl/fl CD11b+ mono-
culture (Figure 14C). These changes are unlikely to be due to differences in cell 
viability, as there was no significant difference in percentage of PI+ cells (Figure 14A). 
While the change in cytokine expression in CD11b+ mono-culture alone may not be 
sufficient to account for the impaired adaptive immune responses, we examined the 
antigen presenting and co-stimulatory molecules and found that LysMcre/Stat3fl/fl 
myeloid cells expressed significantly less MHC Class II, CD40, CD80, and CD86 upon 
LPS and IFNγ stimulation (Figure 12F). The decrease of expression in MHC Class II 
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and co-stimulatory molecules is likely responsible for the decreased T-cells responses in 
the co-culture, which in turn failed to provide enough positive feedback loop to the 
myeloid cells and resulted in decreased secretion of many other cytokines. 
 
 
Figure 14. Cytokine analysis of the ex vivo CD11b+/CD4+ co-culture and CD11b+ mono-culture. A, 
Cell viability of the CD11b+ mono-culture stimulated with 10 ng/ml LPS and 10 ng/ml IFNγ for 24 h was 
evaluated with propidium iodide and flow cytometry. B, C, Cytokine expression of the CD11b+/CD4+ co-
culture after MOG35-55 stimulation for 2 d (B) and the CD11b+ mono-culture after LPS and IFNγ 
stimulation for 24 h (C) was measured by multiplex immunoassay. Stat3fl/fl, n = 3. LysMcre/Stat3fl/fl, n = 3 
(technical replicates). Data represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.005. 
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Stat3 deletion in the peritoneal macrophages was previously reported to cause 
enhanced pro-inflammatory responses [124] due to its role in signaling IL-10 anti-
inflammatory responses [122]. To further characterize STAT3-mediated immune 
responses of macrophages, we prepared BMDMs from bone marrow of Stat3fl/fl and 
LysMcre/Stat3fl/fl mice (Figure 15). The differentiation and maturity of BMDMs were 
first evaluated by flow cytometric analysis of cell surface expression of CD11b and 
F4/80 after 7 days of culture. Both Stat3fl/fl and LysMcre/Stat3fl/fl bone marrow cell 
cultures were mostly mature macrophages (92.8% and 95.7%, respectively; Figure 15A). 
When stimulated with IFNγ, LysMcre/Stat3fl/fl BMDMs expressed less CD40 and CD80, 
but more MHC Class II compared to Stat3fl/fl BMDMs (Figure 15B). LysMcre/Stat3fl/fl 
BMDMs also expressed more pro-inflammatory mediators, e.g., TNFα, IL-1β, IL-6, IL-
12, and MCP-1, at both mRNA (Figure 15C) and protein level (Figure 15D) upon 
stimulation with LPS. When co-cultured with pre-differentiated 2D2 TH1 and TH17 cells, 
the co-cultures secreted comparable amounts of IFNγ and IL-17A between the genotypes 
(Figure 15E). Our results confirmed the previous finding that Stat3-deficient 
macrophages exhibit enhanced innate immune responses [124]. However, our results 
also revealed that cultured BMDMs did not recapitulate the immune responses of 
myeloid cells that are acutely isolated from MOG-immunize mice (Figure 12 and Figure 
14) and further underscore the importance of examining Stat3-dependent immune 
responses in vivo. 
  
 66 
 
 
Figure 15. LysMcre/Stat3fl/fl BMDMs exhibited enhanced proinflammatory responses. BMDMs were 
developed from bone marrow cells in the presence of L929 conditioned medium as described in the 
methods. A, Cell maturity was evaluated by staining with α-CD11b and α-F4/80 after 7 days of culturing. 
Stat3fl/fl, n = 3. LysMcre/Stat3fl/fl, n = 3. B, BMDMs were stimulated with 10 ng/ml IFNγ for 24 h, and then 
stained with α-MHC Class II, α-CD40, α-CD80, and α-CD86 and analyzed with flow cytometry. Stat3fl/fl, 
n = 2. LysMcre/Stat3fl/fl, n = 2.  C, BMDMs were stimulated with 10 ng/ml LPS for 5 hr. Expression of 
cytokine mRNA was measured by quantitative RT-PCR. Stat3fl/fl, n = 3. LysMcre/Stat3fl/fl, n = 3. D, 
BMDMs were stimulated with 10 ng/ml LPS for 24 h. Cytokine secretion into the supernatant was 
measured by ELISA. Stat3fl/fl, n = 3. LysMcre/Stat3fl/fl, n = 3. E, BMDMs were co-cultured with in vitro 
pre-differentiated TH1 or TH17 cells for 1 d (TH1) or 3 d (TH17). Secretion of cytokines was measured by 
ELISA. Stat3fl/fl, n = 2. LysMcre/Stat3fl/fl, n = 2. Data represent mean ± SEM. *p < 0.05, **p < 0.01, ***p 
< 0.005. 
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2.3.7 LysMcre/Stat3fl/fl Mice Are Only Partially Resistant to Passive EAE by Adoptive 
Transfer 
Our data so far suggest that impaired CD4+ T-cell differentiation underlies the 
resistance of Stat3-mutant mice to MOG35-55-induced active EAE. STAT3, however, is 
involved in many cellular processes. As such, in addition to facilitating T-cell 
differentiation, myeloid STAT3 activation could potentially contribute to the 
development of EAE through other mechanisms. To further investigate whether 
impaired T-cell differentiation is indeed the major contributing factor to the resistance of 
LysMcre/Stat3fl/fl mice to active EAE, we induced EAE by adoptive transfer of 
lymphocytes isolated from C57BL/6 EAE mice, therefore bypassing the requirement of 
generating endogenous differentiated T-cells (Figure 16). After isolating and culturing 
the cells from draining LNs from donor mice for 4 days, the donor cell population is 
primarily B-cells, CD4+ T-cells, and CD8+ T-cells (Figure 17A). Of the CD4+ T-cells, 
46.6% and 32.4% were IFNγ-secreting TH1 cells and IL-17A-secreting TH17 cells, 
respectively (Figure 17B). In contrast to active EAE (Figure 6), two thirds of the 
LysMcre/Stat3fl/fl mice developed passive EAE after receiving the encephalitogenic T-
cells (Figure 18A). LysMcre/Stat3fl/fl mice exhibited significantly lower clinical scores 
on average at the peak of disease (Figure 18B). The LysMcre/Stat3fl/fl mice generally 
showed less CNS-infiltrating leukocytes in comparison to littermate controls. However, 
the differences were not statistically significant (Figure 18C). In addition, there was no 
significant difference in mRNA expression of any of the cytokines tested in the spinal 
cord (Figure 18D). Stat3fl/fl and LysMcre/Stat3fl/fl mice of comparable EAE clinical 
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scores also exhibited similar extent of inflammation as determined by 
immunofluorescence in the spinal cord sections (Figure 18E, F). Taken together, 
LysMcre/Stat3fl/fl mice developed less severe adoptive transfer EAE on average than 
Stat3fl/fl mice due to lower onset rate, but are nevertheless susceptible to EAE when 
passively induced by adoptive transfer of encephalitogenic T-cells. 
 
 
Figure 16. Schematic of passive induction of EAE by adoptive transfer of encephalitogenic 
lymphocytes. 
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Figure 17. Donor cells for adoptive transfer EAE consist primarily of lymphocytes. Donor C57BL/6 
mice were immunized with MOG35.55. After 9-10 days, cells from the draining LNs were isolated from the 
mice and cultured in the presence of 20 µg/ml MOG35-55 for 4 d. A, Cell profile after 4 days of culturing 
was analyzed with flow cytometry. B, Protein transport was blocked with Brefeldin A for the last 5 h of 
culturing. the percentage of TH1 and TH17 cells was analyzed with flow cytometry using IgG control (rat 
IgG-PE and rat IgG-FITC) as baseline. 
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Figure 18. LysMcre/Stat3fl/fl mice are partially resistant to passive induction of EAE by adoptive 
transfer. A, B, T-cell adoptive transfer EAE was induced in Stat3fl/fl (n = 20) and LysMcre/Stat3fl/fl (n = 
15) mice, and the clinical score was assessed daily as described in the methods. A, Table of onset rate. B, 
Clinical scores up to 31 dpi. Data represent mean ± SEM. *p < 0.05. C, CNS infiltrating leukocytes were 
isolated from Stat3fl/fl (n = 3) and LysMcre/Stat3fl/fl (n = 3) mice at 30 dpi and counted with a 
hemacytometer. Data represent mean ± SEM. D, Expression of cytokine mRNA in SC from 35 dpi mice 
(Stat3fl/fl, n = 6; LysMcre/Stat3fl/fl, n = 5) were determined with quantitative RT-PCR. Data represent fold 
expression compared to Stat3fl/fl. Data represent mean ± SEM. E, F, Spinal cord cryosections from mice at 
36 dpi were stained with α-Iba-1 (green), α-CD3 (red), and Hoechst. Scale bar (E), 200 µm. Scale bar (F), 
25 µm. 
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2.3.8 STAT3 in the Peripheral Myeloid Cells, but Not in Microglia, Is Important for the 
Development of Active EAE 
It’s been shown that microglia exhibit different accumulation kinetics and gene 
expression than infiltrating monocytes during EAE [141]. During the resolving phase of 
EAE, it has been reported that infiltrating monocytes gradually vanish, whereas 
microglia return to the quiescent state [142]. These findings suggest that microglia may 
function differently than monocytes during EAE. To investigate whether STAT3 in 
microglia contributed to the EAE resistance in LysMcre/Stat3fl/fl mice, we utilized the 
fact that microglia are radio-resistant and created BM chimeric mice by transferring 
donor BM into irradiated recipient mice (Figure 19A). We first tested the percent of 
engraftment using C57BL/6 CD45.2 mice receiving C57BL/6 CD45.1 congenic mouse 
BM (Figure 19B). 6 weeks after transplantation, roughly 85.7% splenocytes possess the 
donor CD45.1 marker (Figure 19B). Because irradiation may potentially damage the 
BBB, causing donor cells to move in the CNS and exhibit microglia-like phenotypes, we 
tested this by transferring LysMcre/rosa26-Ai14 BM into irradiated C57BL/6 mice 
(Figure 19C). 6 weeks after transplantation, SC sections from the naïve mice contain a 
few red fluorescent donor cells at the meninges, but not in the CNS parenchyma (Figure 
19C). These results demonstrated that the bone marrow chimeric mice exhibit high bone 
marrow replacement efficacy but minimal invasion of donor cells to the CNS after 
engraftment, making these mice suitable for investigation of CNS-only or periphery-only 
genetic effects. 
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Figure 19. STAT3 in peripheral myeloid cells, but not microglia, is the major contributor to EAE 
pathogenesis. A, BM chimeric mice were generated by transferring BM cells from donor mice to lethally 
irradiated recipient mice. B, Engraftment efficiency was tested in CD45.2 mice that were irradiated with 
either 700 or 1000 rad and received BM from CD45.1 congenic mice (CD45.1 → CD45.2). 4 weeks after 
transplantation, splenocytes from CD45.1 → CD45.2 mice were stained with α-CD45.1 and α-CD45.2 and 
analyzed with flow cytometry. 700 rad, n = 4, 1000 rad, n = 8. C, C57BL/6 mice were subject to 1000 rad 
irradiation and received BM from LysMcre/rosa26-Ai14 mice (LysMcre/rosa26-Ai14 → C57BL/6). Active 
EAE was induced 6 weeks after transplantation. Spinal cord sections from EAE mice at 21 dpi (EAE) or 
unimmunized mice at 9-week post transplantation (naïve) were stained with α-Iba-1 (green). D-H, Active 
EAE was induced in BM chimeric mice 6-week post transplantation and assessed daily. Stat3fl/fl → 
Stat3fl/fl, n = 11; Stat3fl/fl → LysMcre/Stat3fl/fl, n = 8; LysMcre/Stat3fl/fl → Stat3fl/fl, n = 11; LysMcre/Stat3fl/fl 
→ LysMcre/Stat3fl/fl, n = 4. D, Clinical scores. E, Cumulative scores up to 25 dpi. F, Weight change. G, H, 
CNS infiltrating leukocytes were isolated from mice at 26 dpi and analyzed with flow cytometry. Data 
represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.005. 
 
 
Next, we induced active EAE in the four groups of BM chimeric mice (Figure 
19D-H). Stat3fl/fl mice that received LysMcre/Stat3fl/fl BM (LysMcre/Stat3fl/fl → Stat3fl/fl), 
which possess normal microglia but STAT3-deficient peripheral myeloid cells, did not 
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develop EAE (Figure 19D, E), demonstrating the essential role of STAT3 activation in 
peripheral myeloid cells in the development of EAE. Conversely, LysMcre/Stat3fl/fl mice 
that received wildtype BM (Stat3fl/fl → LysMcre/Stat3fl/fl), which possess STAT3-
deficient microglia but normal peripheral myeloid cells, developed EAE with the 
severity indistinguishable from that of Stat3fl/fl → Stat3fl/fl mice (Figure 19D, E). The 
number of CNS-infiltrating leukocytes was comparable between wildtype mice that 
received wildtype BM (Stat3fl/fl → Stat3fl/fl) and Stat3-mutant mice that received 
wildtype BM (Stat3fl/fl → LysMcre/Stat3fl/fl), whereas wildtype mice that received Stat3-
mutant BM (LysMcre/Stat3fl/fl → Stat3fl/fl) had lower number of CNS-infiltrating cells 
than the other two groups (Figure 19G, H). These data suggest that STAT3 activation in 
the peripheral myeloid compartment, but not in the CNS compartment, is critical for the 
development of EAE. 
Because LysM-driven Cre recombination occurs in roughly a third of the 
microglia population in vivo as determined by flow cytometric analysis of CNS 
mononuclear cells from reporter mice (Figure 5C), our above findings with BM chimeric 
mice (Figure 19) do not completely exclude the possible contribution of microglial 
STAT3. Therefore, we generated new Stat3 conditional mice, employing a newly 
available line (Cx3cr1creER) that allows effective and selective gene targeting of 
microglial cells [137].  
We first tested the efficiency of Cx3cr1-driven Cre recombination by crossing to 
rosa26-Ai14 line (Figure 20A). One week after tamoxifen administration, 13.4% and 
77.9% of circulating granulocytes and Ly6Chi monocytes, respectively, were tdTomato 
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positive (Figure 20B, C). 4 weeks after administration, only microglia were mostly 
tdTomato+ (96.9%), whereas expression in circulating myeloid cells have significantly 
decreased (Figure 20B, C), making these mice a more suitable model to study microglia.  
When we induced active EAE in Stat3fl/fl and Cx3cr1-creER/Stat3fl/fl mice 4 
weeks after tamoxifen administration, the clinical scores did not significantly differ 
between the two groups (Figure 20D, E). There were also no major differences in the 
cytokine mRNA expression from SC from EAE mice (Figure 20F). We also attempted to 
characterize the immune functions of STAT3-deficient microglia in vitro (Figure 21). 
LysMcre/Stat3fl/fl pure primary microglia did not differ in the secretion of TNFα (Figure 
21A). There were also no differences in TNFα, IL-1β, IL-6, IL-12, CCL2, CCL3, or 
CCL5 in LysMcre/Stat3fl/fl primary mixed glial culture (Figure 21B, C). Cx3cr1-
creER/Stat3fl/fl primary pure microglia did not differ in TNFα and IL-6 (Figure 21D). In 
Cx3cr1-creER/Stat3fl/fl primary mixed glial culture, there was an increase in TNFα, but 
not other cytokines tested (Figure 21E, F). Taken together, STAT3 in microglia is 
unlikely to have an important role in EAE. 
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Figure 20. STAT3 in microglia is not critical in pathogenesis of EAE. A, Cx3cr1 -driven Cre 
recombination upon tamoxifen administration splices the Stop codon in the rosa26-Ai14 construct, 
enabling the expression of RFP. B, C, Cx3cr1-creER/rosa26-Ai14 mice (n = 3) were administered with 
two doses of tamoxifen by oral gavage 48 h apart at age of 5 weeks. Expression of tdTomato reporter from 
PBMCs 1 week and 4 weeks after as well as in CNS mononuclear cells 4 weeks after was analyzed with 
flow cytometry. Granulocytes, CD11b+Gr-1+; Ly6Chi monocytes, CD11b+Ly6Chi; T-cells, CD3+; B-cells, 
CD19+; Microglia, CD11b+CD45int.  C-E, Cx3cr1-creER/Stat3fl/fl (n = 17) and littermate Stat3fl/fl mice (n = 
21) were administered with tamoxifen at age of 5 weeks. Active EAE was induced 4 weeks after and 
assessed daily. C, Clinical scores. D, Cumulative scores up to 30 dpi. E, Cytokine mRNA expression from 
SC tissue at 30 dpi (Stat3fl/fl, n = 8; Cx3cr1-creER/Stat3fl/fl, n = 6) was analyzed with quantitative RT-PCR. 
Data represent fold expression compared to Stat3fl/fl. Data represent mean ± SEM. 
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Figure 21. Innate immune responses in primary microglia and mixed glial cultures. A, Primary 
microglia from Stat3fl/fl (n = 2) and LysMcre/Stat3fl/fl (n = 2) was stimulated with 10 ng/ml LPS for 24 hr. 
TNFα secretion was measured by ELISA. B, C, Primary mixed glia from Stat3fl/fl (n = 5) and 
LysMcre/Stat3fl/fl (n = 4) was stimulated with 10 ng/ml LPS for 24 hr (B) or 5 hr (C). B, Cytokine 
secretion was measured by ELISA. C, Cytokine mRNA expression was determined by qRT-PCR. D, 
Primary microglia from Stat3fl/fl (n = 2) and Cx3cr1creER/Stat3fl/fl (n = 2) was stimulated with 10 ng/ml 
LPS for 24 hr. TNFα and IL-6 secretion was measured by ELISA. E, F, Primary mixed glia from Stat3fl/fl 
(n = 5) and Cx3cr1creER/Stat3fl/fl (n = 3) was stimulated with 10 ng/ml LPS for 24 hr (E) or 5 hr (F). E, 
Cytokine secretion was measured by ELISA. F, Cytokine mRNA expression was determined by 
quantitative RT-PCR. Data represent mean ± SEM. *p < 0.05. 
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2.4 Discussion 
In this section, we demonstrate that STAT3 in peripheral myeloid cells is 
essential in the development of CNS pathologies in an animal model of MS. We show 
that conditional deletion of Stat3 in myeloid cells using LysMcre/Stat3fl/fl mice results in 
resistance to MOG35-55-induced EAE in C57BL/6 mice (Figure 6). LysMcre/Stat3
fl/fl mice 
exhibit diminished helper T-cell immune functions during the pre-clinical and onset 
stages of the disease when compared to Stat3fl/fl mice (Figure 8). Myeloid cells isolated 
from immunized LysMcre/Stat3fl/fl mice fail to differentiate naïve 2D2 CD4+ T-cells and 
expressed less antigen presenting and co-stimulatory molecules (Figure 12). Passively 
inducing EAE by adoptive transfer of autoreactive T-cells, thereby bypassing the need to 
differentiate endogenous CD4+ T-cells, renders LysMcre/Stat3fl/fl mice partially 
susceptible (Figure 18). In contrast to peripheral STAT3, microglial STAT3 does not 
have a significant role in EAE pathogenesis (Figure 19, Figure 20).  
Stat3 dys-regulation has been implicated in many cancer studies, and several of 
its inhibitors has been in use or on clinical trials [143, 144]. Stat3 in monocytes is also 
shown to be up-regulated in rheumatoid arthritis [145], which is also an autoimmune 
disease and suggest its close relationship with autoimmunity. LysMcre/Stat3fl/fl BMDMs 
exhibited enhanced proinflammatory responses in our study, consistent with the finding 
that Stat3 signals IL-10 anti-inflammatory responses in myeloid cells [122, 146-148]. 
STAT3 has also been shown to be a negative regulator of DC functions and decrease 
MHC II expression in DCs [149, 150]. The enhanced proinflammatory response in the 
absence of its negative feedback could, in theory, cause more severe pathologies in 
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autoimmune diseases. Our results, however, indicated otherwise in autoimmune 
demyelination disease. Not only LysMcre/Stat3fl/fl mice are resistant to active EAE, the 
myeloid cells isolated from immunized LysMcre/Stat3fl/fl mice also failed to differentiate 
T-cells. It is possible that the in vitro derived BMDMs and BMDCs, albeit widely 
utilized by many studies, are intrinsically less relevant and the results from the 
experiments using these cells do not translate well in in vivo conditions, where the 
responses from the cells are the net result of many more stimulants and environmental 
factors.  
In this study, we demonstrated that STAT3 is involved in the expression of 
antigen presenting and co-stimulatory molecules in the APCs, which participate in the 
differentiation of encephalitogenic T-cells during MOG-induced EAE (Figure 22). It is 
important to bear in mind, however, that Stat3 is a gene with pleotropic functions [151]. 
It is possible that the resistance to EAE in LysMcre/Stat3fl/fl mice is a combined result 
from multiple pathways and in different cell types. When we induced EAE by adoptively 
transferring autoreactive CD4+ T-cells, thereby bypassing the requirement to 
differentiate and activate endogenous CD4+ T-cells, LysMcre/Stat3fl/fl mice developed 
EAE although with lower severity than Stat3fl/fl mice, strongly suggesting the 
involvement of additional mechanisms. Neutrophils have been shown to be essential in 
the onset phase of EAE [152] without affecting CD4+ T-cell differentiation. Although 
STAT3 possesses modulatory roles in neutrophil immune functions [153], studies also 
show that STAT3 signals G-CSF-induced expression of CXCL2 [154], and that bone 
marrow STAT3-deficient mice show impaired neutrophil mobilization [155]. Moreover, 
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deletion of SOCS3, a STAT3 inhibitor, in myeloid cells causes a more severe form of 
atypical EAE, and that is mainly mediated by neutrophils [114, 127]. Although we did 
not find a consistent difference in the number of circulating neutrophils in 
LysMcre/Stat3fl/fl mice, possible changes in their functions that are relevant to 
autoimmunity remain to be investigated.  
 
 
Figure 22. Proposed mechanism of myeloid STAT3 in EAE pathogenesis. Upon MOG35-55 
immunization, STAT3 is involved in upregulation of MHC Class II, CD80, CD86, and CD40 on the cell 
surface of APCs. This facilitates the differentiation of encephalitogenic T-cells, leading to the 
development of EAE. Additionally, STAT3 may also be involved in myeloid cell functions independent of 
T-cell differentiation, thus contributing to EAE pathogenesis. 
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During EAE, leukocytes in the blood stream transmigrate across the blood-brain 
barrier into the CNS parenchyma to cause damage. Proteins of the matrix 
metalloproteinase (MMP) family, mainly secreted by myeloid cells [51], digest the 
extracellular matrix and facilitate the diapedesis [81, 82]. STAT3 is shown to be at least 
partially involved in MMP-2 and MMP-9 expression [128, 129], suggesting a possible 
role in facilitating cell diapedesis. However, studies investigating the effects of MMP 
knockouts yielded mixed results [83] presumably due to the fact that different MMPs 
can complement each other’s functions. Therefore, the role of myeloid STAT3 in 
leukocyte transmigration requires further investigation. 
We understand that most animal models with genetically modified mice are not 
perfect and ours is no exception. LysMcre/Stat3fl/fl mice and other similar lines were 
shown to develop spontaneous enterocolitis and the onset increases with age [124, 149, 
156]. The inflamed gastrointestinal tract will likely disrupt the balance in commensal 
microbiota, which has been shown to have profound effects in EAE and other 
autoimmune diseases [157]. We induced EAE at relatively young age (6-7 weeks), and 
only a few of our LysMcre/Stat3fl/fl mice developed rectal prolapse during or before EAE 
induction (Table 3). Although the mice with rectal prolapse did not develop actively 
induced EAE, neither did most other LysMcre/Stat3fl/fl mice. Interestingly, all of our 
mice with rectal prolapse still developed passively induced EAE by adoptive transfer. 
Therefore, the EAE resistance conferred by myeloid STAT3 deletion cannot be solely 
explained by its effect on the commensal microbiota. 
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Table 3. Anal prolapse in the LysMcre/Stat3fl/fl mice.  
LysMcreStat3fl/fl mice EAE Onset/Total EAE Onset/Anal Prolapse 
Active EAE 2/36 0/2 
Adoptive EAE 10/15 2/2 
 
 
In our EAE experiment involving bone marrow chimeric mice, we discovered 
that although LysMcre/Stat3fl/fl → Stat3fl/fl mice did not develop EAE (Figure 19D), they 
displayed sickness behaviors and appeared hunched and lethargic. They also lost a 
significant amount of body weight (Figure 19F). These mice, however, did not develop 
other symptoms associated with atypical EAE such as ataxia and axial rotation. We 
found one mouse exhibiting cerebellum inflammation (Figure 23A) but not in the other 
mice. We speculate that the enhanced innate immune response in their system elicited by 
the injection of CFA caused a septic shock in these mice, as we discovered that the 
serum from LysMcre/Stat3fl/fl mice at pre-clinical stage contain elevated levels of TNFα 
(Figure 23B, C). This is supported by the fact that the LysMcre/Stat3fl/fl → Stat3fl/fl mice 
did not exhibit any apparent health problems or weight loss prior to immunization. 
Although we are uncertain as to why regular LysMcre/Stat3fl/fl and chimeric 
LysMcre/Stat3fl/fl → LysMcre/Stat3fl/fl mice did not exhibit significant weight loss, we 
speculate that their system adapted to the enhanced response during development, 
whereas the heightened immune responses in LysMcre/Stat3fl/fl → Stat3fl/fl mice elicited 
sickness behaviors. 
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In summary, we found that Stat3 in myeloid cells is critically important in the 
development of EAE. Myeloid cells in LysMcre/Stat3fl/fl mice express less antigen 
presentation and co-stimulatory molecules, and exhibit impaired capability to 
differentiate CD4+ T-cells. We provide evidence that Stat3 may be a therapeutic target in 
autoimmune diseases in the CNS. Our future direction would be to investigate the 
cellular mechanisms in which Stat3 influences expression of antigen presentation and 
co-stimulatory molecules, and their possible specific functions in different subsets of 
myeloid cells. 
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Figure 23. Bone marrow chimeric mouse cerebellum and preclinical mouse serum. A, 
LysMcre/Stat3fl/fl → Stat3fl/fl mice were induced with active EAE. At 17 dpi, 2 mice were sacrificed due to 
moribundity. Brain tissue was cryosectioned and stained with hematoxylin, α-Iba-1, Hoechst, and oil-red-
O. Representative pictures were shown. B, Stat3fl/fl (n = 6) and LysMcre/Stat3fl/fl mice (n = 5) were induced 
with active EAE. At 12 dpi, serum samples were obtained from mouse blood. Level of TNFα in the serum 
was measured by ELISA. C, Stat3fl/fl (n = 4) and LysMcre/Stat3fl/fl mice (n = 3) were induced with active 
EAE. At 14 dpi, serum samples were obtained from mouse blood. Level of TNFα in the serum was 
measured by ELISA. Data represent mean ± SEM. *p < 0.05.  
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3. THE ROLE OF MICROGLIAL STAT3 IN BRAIN DEVELOPMENT 
 
3.1 Introduction  
Microglia are the tissue-resident macrophages of the CNS and consist roughly 
10-15% of CNS cell population. Microglia arise from a process called primitive 
hematopoiesis that occurs in the yolk sac and migrate towards the CNS from E7.5 in 
mice [64-67], a process distinct from the adult hematopoiesis, in which the blood cells 
are formed from the hematopoietic stem cells. Studies that utilize techniques such as 
parabiosis [158] and Cx3cr1creER/iDTR mice [159] have demonstrated that microglia 
are replenished by self-renewal, unlike the bone marrow-derived leukocytes. Microglia 
exhibit different accumulation kinetics and gene expression than infiltrating monocytes 
during EAE [141]. Moreover, it’s also shown that although bone marrow-derived 
monocytes can enter the CNS lesion sites during EAE, they do not stay in the CNS and 
contribute to the microglia population after disease resolution [142], further indicating 
the difference between microglia and monocytes. As the tissue-resident macrophage, 
microglia can become activated via pattern recognition receptors and carry out immune 
functions such as proinflammatory mediator secretion, phagocytosis, antigen 
presentation and more [160]. In their resting state, microglia exhibit a non-overlapping 
distribution in the CNS [161] and remain highly dynamic and are actively surveying the 
environment by constantly sending out and retrieving processes [162].  
Despite having an immune cell origin, microglia have many functions related to 
the development of the nervous system, some of which utilizing their immune cell 
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functions. During early development, more neurons than needed are initially formed, and 
the number is subsequently reduced via programmed cell death [163, 164]. For example, 
most newborn neurons in the subgranular zone of the dentate gyrus undergo apoptosis, 
and are quickly cleared by phagocytosis [165]. Microglia use their phagocytic capability 
to clear up the dead cells [166], creating space for the nervous system to continue to 
develop. Microglia are also shown to be able to actively induce programmed cell death 
in neurons [167-170]. Using retinal cultures with or without microglia, it was shown that 
microglial-derived nerve growth factor (NGF) induces neuronal death in developing 
retina [167]. Microglia and their secretion of TNFα enhanced the programmed cell death 
“competence” in motoneurons from rat E13 embryo explants [168]. In TNFα- or TNFR-
deficient mice, programmed cell death in E11 explants were reduced in half compared to 
WT [168]. Other microglial-derived factors such as nitric oxide (NO) [169] and reactive 
oxygen species (ROS) [170] on neuronal cell death have also been reported. Microglia 
have also been shown to regulate the number of neural precursor cells (NPCs) in the 
developing embryo. Microglial activation by LPS injection in the pregnant mice at E15 
decreased number of NPCs, whereas inhibition of microglia with doxycycline increased 
the number of NPCs [171]. Microglia are also shown to influence neurogenesis through 
secretion of growth factors. Macrophages and microglia are the major sources of insulin-
like growth factor-1 (IGF-1) [172]. IGF-1 secretion from the microglia that are 
stimulated with IL-4 can induce neurogenesis in neural progenitor cells [173]. 
Microglia-derived IGF-1 was also shown to promote the survival of neurons in layer V 
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cerebral cortex [174]. Together, these studies strongly suggest that microglia are actively 
involved in regulating neuronal cell number in the developing brain. 
During development, synaptic connections are initially formed excessively, and 
subsequently undergo remodeling and elimination in a neuronal activity-dependent 
fashion [175]. It has been found that neurons in the developing brain express the 
complement protein C1q at the synapses [176]. Normally, the lateral geniculate nucleus 
(LGN) segregates into regions containing neurons that respond to either the left eye or 
the right eye, but not both. In C1q-KO mice, the LGN was not segregated, and the 
neurons remained innervated by both eyes [176]. The same group also found that 
microglia were located at the synapses and phagocytosing the inputs from the retinal 
ganglion cells (RGC). Using tetrodotoxin and CR3-KO mice, they also found that the 
phagocytosis of RGC inputs was dependent on neuronal activity and the complement 
receptor CR3 on microglia [177]. Consistent with this, CX3CR1 KO mice showed 
increased number of immature dendritic spines in the first two postnatal weeks [178]. 
These studies indicate that microglia are actively involved in remodeling of synaptic 
connections during development. In addition to synaptic remodeling, developing axons 
undergo an elimination process during development, and microglia with vacuoles 
containing inclusions were observed under electron microscopy, suggesting its 
phagocytic activity during axonal pruning [179]. It’s also found that dopaminergic axons 
in the forebrain during development “over-extend” in microglia-deficient (Pu.1-KO) or -
depleted (CSF1R Ab) mice [180], suggesting the involvement of microglia in axonal 
pruning. 
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Many behavioral disorders such as stress related disorders and autism spectrum 
disorders are connected to abnormal neural circuits in various brain regions [181, 182]. 
Since microglia arrive at the CNS early during development and are involved multiple 
aspects of neuronal development, abnormalities in microglia could lead to abnormal 
brain circuitry, which could then translate to behavioral deficits. CX3CR1 is a 
fractalkine receptor that is highly expressed in microglia, and the CX3CR1-fractalkine 
interaction modulates microglial activation [183]. Cx3cr1-KO mice showed a transient 
decrease of microglia during early postnatal development and consequent deficit in 
synaptic multiplicity and functions connectivity across multiple brain regions [184]. 
These mice also showed reduced social behaviors and increased repetitive behaviors 
such as self-grooming. Depleting microglia with the Cx3cr1creER/iDTR mice caused 
altered synaptic protein levels and reduced performance improvement in the rotarod test 
[137]. M-CSFR signaling is required for macrophage and microglial survival. M-CSFR 
KO mice showed nearly complete deletion of microglia, had enlarged ventricles and 
compressed CNS parenchyma, and exhibited impaired olfactory functions in a food-
finding test [185]. Depleting microglia with clodronate liposome at P1 and P4 in rats 
leads to reduced anxiety in elevated maze and open field tests, increased locomotor 
activity, decreased chasing behaviors during social play, and decreased despair, i.e. 
immobile time, in forced swim test [186]. Similarly, depleting microglia with clodronate 
liposome at P0, 2, 4 in rats leads to reduced anxiety, increased locomotion, and deficits 
in male sex behaviors [187]. Besides microglial cell depletion, changing the activation 
state of microglia has also been shown to have behavioral effects. s.c. injection of E. coli 
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in P4 rat pups caused a memory forming deficit in the fear conditioning test in the adults 
(P60-63) when followed by peripheral immune challenge with i.p. injection of LPS 
[188]. The offspring of mice subjected to maternal immune activation mothers by i.p. 
injection of poly(I:C) at E10.5, 12.5, and 14.5 exhibited decreased sociability and 
increased compulsive behaviors in both marble burying and self-grooming [189]. These 
studies indicate that manipulations in microglia can lead to profound behavioral 
abnormalities. 
While studies indicate that STAT3 is involved in neurogenesis and 
astrogliogenesis [97-99], whether STAT3 is involved in microglial formation is not 
clearly understood. Microglia arise from primitive hematopoiesis beginning with 
embryonic stem cells (ESCs). Many key factors controlling microglia development were 
identified, and include Runx1, C/EBPα, PU.1, IRF-8, M-CSFR, miR-124, and more 
[190-192]. Adult definitive hematopoiesis begins with hematopoietic stem cells (HSCs). 
The development of bone marrow derived monocytes involves multiple stages. Briefly, 
C/EBPα is required for developing from multipotent progenitors (MP) to common 
myeloid progenitors (CMP); PU.1 is required for developing from CMP to granulocyte-
macrophage progenitors (GMP); M-CSFR is required from GMP to monocytic 
progenitors (MP) [191]. Although the discovery of microglial origin is relatively new 
and the detailed stages involved are not as clear, the overlapping of several key factors, 
namely C/EBPα, PU.1, and M-CSFR, suggests that the two hematopoietic processes 
may share similar developmental stages. Between these factors, C/EBPα can directly 
induce PU.1, which induces M-CSFR [191, 193]. M-CSFR signals mainly through PI3-
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kinase and MAPK pathways [194-196]. However, an early report showed M-CSFR 
induces STAT3 activation [197]. Interestingly, IL-34, a cytokine with overlapping 
functions with M-CSF, also signals through M-CSFR and was shown to be important in 
microglial development [198]. IL-34 was shown to activate STAT3 and to induce 
expression of osteoclast-related genes in the bone marrow macrophages during 
osteoclastogenesis, which can be blocked by AG490 [199]. IL-34 was also shown to 
activate STAT3 in the fibroblast-like synovial cells from rheumatoid arthritis patients 
[200]. Therefore, JAK/STAT pathway might be involved in microglia formation through 
M-CSFR signaling.  
Another possibility of JAK/STAT involvement is through GM-CSF. GM-CSF is 
implicated in myelopoiesis, and its receptor GM-CSFRα signals through JAK2/STAT3 
and STAT5 pathways [201]. Stimulation of GM-CSF is involved in transition from CMP 
to GMP, the step in which PU.1 is required. It has also been shown that PU.1 mediates 
GM-CSF in alveolar macrophage differentiation [202], and that STAT3 induces PU.1 
expression [203, 204]. Therefore, GM-CSF might signal through STAT3 and induce 
PU.1, thereby contributing to the differentiation from CMP to GMP. It’s also reported 
that high level of PU.1 skews the development towards MP [193], thus the GM-CSF 
signaling may contribute to such high level of PU.1. It is to be noted that myelopoiesis in 
GM-CSF knockout mice appears normal. Therefore, GM-CSF and its signaling through 
JAK/STAT pathways may play a modulatory role for myeloid function, rather than 
being essential in myeloid development. 
 90 
 
STAT3 was reported to become activated in a microglial cell line after 
radiofrequency (RF) electromagnetic field exposure, and the STAT3 inhibitor Stattic 
reduced RF field-induced expression of pro-inflammatory cytokines such as TNFα, IL-
1β, IL-6, and NO [205]. STAT3 and STAT1 together were also shown to target Jmjd3, 
which in turn drives other pro-inflammatory cytokines in response to LPS in microglia 
[206]. These studies suggest that STAT3 may have a pro-inflammatory effect in 
microglia, although these studies utilized cell lines, so the applicability requires further 
testing.  
Strong evidence of STAT3 in microglia development and/or activation is still 
sparse. However, STAT3 is a regulatory gene that is involved in many functions across 
different cell types. In this section, we attempted to study the role of STAT3 in microglia 
development and possible effects on behavioral changes in mice with inducible ablation 
of microglial STAT3. 
 
3.2 Materials and Methods 
3.2.1 Animals 
STAT3fl/fl mice contain two loxP sites that flank exon 22 of Stat3 gene [135], 
were a generous gift from Dr. Shizuo Akira (Hyogo College of Medicine, Nishinomiya, 
Japan), and were backcrossed to C57BL/6 mice for 8 generations. Cx3cr1creER mice 
express an enhanced yellow fluorescent protein (EYFP) and a Cre recombinase linked to 
a mutated estrogen receptor that binds to tamoxifen under control of Cx3cr1 promoter 
[137]. Conditional mutant mice were generated by crossbreeding Stat3fl/fl mice to 
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Cx3cr1creER mice. Stat3fl/fl;Cx3cr1-creER+/- and Stat3fl/fl;Cx3cr1-creER-/- littermates 
were used in the experiments. B6.129P2(Cg)-Cx3cr1tm2.1(cre/ERT2)Litt/WganJ mice 
(Cx3cr1creER) and B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J mice (rosa26-Ai14) 
were obtained from Jackson Laboratory (Bar Harbor, ME). Mice were under husbandry 
and bred in the animal facility in Texas A&M University Comparative Medicine 
Program. All animal use was approved by Institutional Animal Care and Use Committee 
in Texas A&M University. 
3.2.2 Administration of Tamoxifen 
Tamoxifen (T5648, Sigma-Aldrich) was administered in either adults or neonatal 
Cx3cr1-creER/Stat3fl/fl mice. For the adults, tamoxifen was first dissolved in corn oil 
(C8267, Sigma-Aldrich) at 40 mg/ml by incubating while shaking at 37°C for 30 min 
followed by pulse sonication. Each mouse at age of 5 weeks received 2 doses of 8 mg 
tamoxifen (in 200 µl corn oil) by oral gavage, 48 hr apart. For the neonatal mice, 10 mg 
tamoxifen was first dissolved in 250 µl ethanol by vortexing. 750 µl corn oil was then 
added to achieve 10 mg/ml (10x). The solution was stored at 4°C and used for one 
experiment before disposal. Each day for P1-P3, the 10x solution was diluted 1:10 in 
corn oil to achieve 1 mg/ml. Each pup received intragastric injection of 50 µg tamoxifen 
(in 50 µl volume) daily for P1-P3. 
3.2.3 Behavioral Tests 
In all animal behavioral tests, the mice were housed in groups and in a 12-hr 
light/dark cycle. The mice were transferred in their home cage to the test room and left 
undisturbed for 30 min before the experiments were conducted. All behavioral tests were 
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conducted during the light phase of the day cycle. The same behavioral test was 
conducted at the same time of a day for all animals. Other than the Morris Water Maze 
test, the lighting conditions in the test rooms were approximately the same as the regular 
housing room, and the room temperature was set at 21°C. 
Open Field. The open field test to measure anxiety and explorative behavior was 
described previously [207, 208] and was performed using the Tru Scan Activity System 
(Coulbourn Instruments, Holliston, MA). Before the experiment, all the equipment was 
sprayed and wiped with 70% ethanol. Each mouse was placed in the center of an open 
field arena of size 26 cm × 26 cm to allow exploration for 30 min. Mouse activity during 
the 30 min was recorded by two infrared sensor rings, one for the floor plane and the 
other for the vertical plane. After each test, the mouse was returned to its home cage, the 
feces were removed from the arena, and the arena was cleaned with 70% ethanol and let 
dry before subsequent tests. Perimeters including total movements, movement time, 
movement distance, average distance per move, mean velocity, number of jumps, rest 
time, margin distance, margin time, center distance, center time, center entries, vertical 
plane entries, and vertical plane time were collected on the Tru Scan 2.0 software. The 
data was collected in 2-min intervals.  
Marble Burying. The mice were first translocated in their home cage to the test 
room and habituated for 30 min. A clean mouse cage of approximate size 28 cm × 17 cm 
was prepared for each mouse and contains 5-cm deep SANI-CHIP bedding. The bedding 
was pressed by hand to create a flattened surface. 10 white marbles of size 1.45 cm in 
diameter were placed in a “3 by 3 plus 1” pattern on the bedding (Figure 24). Food and 
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water were withheld from the testing cages. Each mouse was placed in the center of one 
testing cage. The cages were covered with cage tops and left undisturbed for 30 min. 
After the test, the mice were returned to the home cage, and the number of marbles that 
were at least 70% buried in bedding was recorded. 
 
 
Figure 24. Placement of marbles for the marble burying test. 
 
 
Social Interaction. The social interaction test to assess sociability was described 
previously [209]. In a 3-chamber apparatus of approximate size 60 cm × 40 cm (Figure 
25), a mouse was placed in the center chamber for habituation for 10 min while the 
doors to the other chambers were closed. An inverted empty metal wire pencil cup was 
placed in one of the side chambers, and another inverted empty metal wire pencil cup 
holding a stranger male mouse was placed in the chamber on the opposite side. After 10 
min of habituation, the doors connecting the 3 chambers were removed. The mouse 
activity was recorded for another 10 min. The time spent in the novel stranger chamber 
(“Stranger”), the time in the novel object chamber (“Opposite”), and the time interacting 
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with the stranger mouse was noted. The interaction was defined as when the tested 
mouse was sniffing with its nose within 1 cm of the stranger cup. 
 
 
Figure 25. Illustration of the three-chamber social interaction device. 
 
 
Rotarod. The rotarod test to assess motor coordination was carried out following 
the Standard Operating Procedures on EUMORPHIA and using a Rota-rod Treadmill 
apparatus (#7650; Ugo Basile Biological Research Apparatus, Varese, Italy). The mice 
were first translocated in their home cage to the test room and let accommodate for 30 
min. Meanwhile, the rotarod apparatus was thoroughly cleaned and dried with 70% 
ethanol and paper towels. For each trial, the apparatus was initially set at a constant 4 
rpm speed, while up to 3 mice were placed onto separate lanes on the apparatus, facing 
forward. After all mice were correctly positioned and oriented, the apparatus was 
switched to the accelerating mode, in which the rotating speed increases from 4 rpm to 
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40 rpm in 300 sec. The latency until each mouse fell from the treadmill was recorded. 
Mice that clung on the rod for a full passive rotation counted as a “fall” and were 
returned to the cage. Mice that stayed on the treadmill for the whole 300-sec duration 
had the latency to fall value recorded as 300. The apparatus was cleaned with 70% 
ethanol, and the procedure was repeated for all other mice to complete the first trial. 
Each day consisted of 3 trials, with 15 min inter-trial interval between each trial. The 
procedure was repeated for a total of 3 consecutive days. 
Morris Water Maze. The MWM to test spatial learning was performed as 
described previously [210, 211] with modifications. A water bucket of size 120 cm in 
diameter was filled with tap water in the test room in which the room temperature was 
set at 78°F (25.6°C). The water was left for a day in order for its temperature to reach the 
corresponding room temperature. The mice underwent 6 trials per day, 3 days of visible 
platform training (day 1-3). During the visible platform training, the water bucket was 
surrounded by white curtain, but no visual cues were present. A platform of size 15.5 cm 
in diameter was place 1 cm above the water level. For each trial, each mouse was 
allowed to swim in the pool for up to 2 min. If the mouse reaches the platform, it is 
allowed to sit on the platform for 20 s before returning to its home cage. If the mouse 
does not reach to platform within 2 min, it is guided to the platform and allowed to sit 
for 20 s before returning to its home cage. After the visible platform training, the mouse 
underwent 3 trials per day, 6 days of hidden platform training (day 4-9). During the 
hidden platform training, the water was made opaque by adding non-toxic white tempera 
paint. The platform was placed 5 mm below water level. Three high-contrast visual cues 
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were placed on the surrounding curtain. During each trial, a mouse was allowed to swim 
for up to 60 s. If the mouse reaches the platform, it is allowed to sit on the platform for 
15 s before returning to its home cage. If the mouse does not reach to platform within 60 
s, it is guided to the platform and allowed to sit for 15 s before returning to its home 
cage. The mouse’ swimming trail was captured and analyzed on the WaterMaze 
software (Coulbourn Instruments, Holliston, MA). On day 4 before the hidden platform 
training, day 9 two hours after the hidden platform training, and day 10, three trials of 
probe tests were performed for each mouse. During the probe test, the setup remained 
the same as the hidden platform training except that the platform was absent. The 
software captures the swimming trail during the 60 s and computes average proximity 
and percent time spent in the platform quadrant. 
3.2.4 Isolation of Fresh Neonatal Microglia for RNA Sequencing 
Neonatal mice were administered with tamoxifen daily from P1-P3. At P6, toe 
clips were obtained for determining the genotypes. At P8, the mice were anesthetized 
with ketamine and xylazine, and transcardially perfused with 10 ml PBS. The skin 
around the head was removed. The skull was cut open along the midline from the 
posterior end, and the brain was removed with a scoop. The brain was disrupted with 
scissors and digested in 5 ml Stempro Accutase (A11105-01; Life Technologies, 
Carlsbad, CA) at 37°C for 30 min. Every 5 min during the incubation, the tube was 
inversed several times to mix the content. After the 30-min incubation, the enzyme 
activity of Accutase was blocked by addition of 2 ml FBS. The digested tissue was then 
filtered through a 70-μm cell strainer with the help of a 3-ml syringe plunger to make 
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single cell suspension. Cells were centrifuged and resuspended in 5 ml 35% Percoll 
(P4937; Sigma-Aldrich) in PBS. 3 ml 70% Percoll was slowly added to the bottom with 
a Pasteur pipette attached to a rubber bulb. The tubes were then centrifuged at 2,000 × g 
for 20 min at 18°C with the brake set to 0. The top lipid/myelin layer was quickly 
removed using a pipette. Cells in the interphase between the 35% and 70% Percoll layers 
were harvested with a Pasteur pipette, washed by centrifugation and resuspended in ice-
cold PBS. The cells were stained with α-ms CD11b APC (#17-0112; eBioscience), 
washed and resuspended in PBS containing propidium iodide and 1 mM EDTA. 
CD11b+PI- cells were FACS-sorted and resuspended in 500 µl Tri Reagent, flash frozen 
and stored at -80°C until use. RNA was isolated using Direct-zol RNA MiniPrep kit 
(R2052; Zymo Research) following the instruction manual. 
3.2.5 Histological Analysis of P10 and P32 Mouse Brains 
Mice were administered with tamoxifen daily from P1-P3. At P10 or P32, the 
mice were transcardially perfused with PBS. The brains were removed and fixed in 4% 
PFA in PBS at 4°C overnight. The next day, the tissues were changed to 30% sucrose in 
PBS for cryoprotection for roughly two days until they sank. The tissues were embedded 
in Tissue-Tek O.C.T. Compound (#4583, Sakura Finetek USA, Inc., Torrance, CA) and 
frozen-sectioned into 10 μm sagittal sections on Leica CM1950 cryostat (Leica, 
Nusslock, Germany). The sections were adhered onto Superfrost Plus Microscope Slides 
(Fisher Scientific, Waltham, MA) and stored at -20°C until use. 
The slides were thawed and dried for 30 min to 1 hr at 37°C prior to staining. For 
immunofluorescence, appropriate regions of the slides were marked with an ImmEdge 
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hydrophobic barrier pen (Vector Lab, Inc. Burlingame, CA) to separate different 
sections. The sections were rinsed in PBS twice for 5 min each to remove the O.C.T. 
Compound. Sections were blocked for unspecific binding and permeabilized with PBS 
containing 5% goat serum and 0.3% Triton X-100 (T9284, Sigma Aldrich) for 1 hr at 
room temperature, and incubated with rabbit α-Iba-1 (1:400; #019-19741, Wako, 
Richmond, VA), chicken α-GFP (A10262, Invitrogen), or mouse anti-NeuN (1:200; 
MAB377, Millipore) diluted in PBS containing 5% goat serum and 0.1% Triton X-100 
at 4°C overnight. The next day, tissue sections were washed in PBS three times for 5 
min each, and incubated with Alexa Fluor 488 goat α-rb IgG (A11034, Invitrogen, 
Eugene, OR), Alexa Fluor 488 goat α-ms IgG (A11029, Invitrogen, Eugene, OR), or 
Alexa Fluor 488 goat α-rat IgG (A11006, Invitrogen, Eugene, OR), diluted 1:1000 in 
PBS containing 5% goat serum and 0.3% Triton X-100 for 1 hr in dark at room 
temperature, followed by three washes in PBS. Cell nuclei were stained with Hoechst 
33342 (Invitrogen) at 1:1000 dilution in PBS for 2 min. Images of sections were 
obtained under an Olympus IX71 microscope (Olympus, Tokyo, Japan) and its 
proprietary imaging software at constant settings across different sections/samples. Post-
processing (image merging and background removal) was performed in a uniform 
fashion in Adobe Photoshop software. Number of cells was counted and divided by the 
counting area to obtain the cells density from multiple fields in the cerebral cortex using 
ImageJ software. 
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3.3 Results  
3.3.1 Neonatal Deletion of Microglial STAT3 Causes a Transient Reduction of 
Microglial Number in the Cerebral Cortex 
To investigate the role of STAT3 in microglial development and functions, 
tamoxifen was administered daily from P1-P3 in Cx3cr1creER/Stat3fl/fl mice and Stat3fl/fl 
littermates (Figure 26). The efficiency of Cre recombinase expression was first assessed 
using the rosa26-Ai14 reporter line. At P6, most YFP-expressing microglia are also 
tdTomato positive in the brain (Figure 27A), indicating high efficiency of recombination. 
Granulocytes and Ly6Chi monocytes in the spleen at P6 are 98.0% and 97.0% tdTomato 
positive, respectively, whereas little expression was found in B-cells and T-cells (Figure 
27B). 
After establishing the efficacy of tamoxifen-induced recombination in CX3CR1+ 
myeloid cells in the CNS, we then assessed number of microglia and neurons in the CNS 
in Cx3cr1creER/Stat3fl/fl and Stat3fl/fl mice at two different ages with 
immunohistochemistry (Figure 28). At P10 in the frontal cortex, a dense Iba-1+ 
microglia population was observed in the Stat3fl/fl mice (Figure 28A), whereas the 
microglia distribution in the Cx3cr1creER/Stat3fl/fl mice was rather sparse (Figure 28B). 
Further analysis by cell counting revealed a significant reduction in the number of 
microglia in the Cx3cr1creER/Stat3fl/fl mice as compared to Stat3fl/fl controls (Figure 
28D). Preliminary histological analysis of Nissl staining suggested that the number of 
neurons in the cortex was modestly increased in Cx3cr1creER/Stat3fl/fl mice in 
comparison to Stat3fl/fl controls (Figure 28C, E). In contrast to P10, the number of 
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microglia or neurons were not significantly different at 4 weeks of age (P32; Figure 28F, 
G). Taken together, these results indicate a transient reduction of microglia in the second 
postnatal week of Cx3cr1creER/Stat3fl/fl mouse brain, but the microglial number 
recovered by one month of age. 
 
 
Figure 26. Schematic of developmental and behavioral experiments in the microglial STAT3-mutant 
mice. 
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Figure 27. Cx3cr1-driven Cre recombination upon neonatal administration of tamoxifen. 
Cx3cr1creER/rosa26-Ai14 mice (n = 8) received daily intragastric injection of 50 µg tamoxifen from P1-
P3. The mice were sacrificed at P6. A, Coronal brain sections were stained with α-YFP (green) and 
Hoechst. A representative picture is shown. B, Splenocytes were isolated and stained with antibodies for 
cell surface markers and analyzed with flow cytometry. Granulocytes, CD11b+Gr-1+; Ly6Chi monocytes, 
CD45+Ly6Chi; B-cells, CD19+; T-cells, CD3+. Data represent mean ± SEM. 
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Figure 28. Number of microglia is transiently reduced in the Cx3cr1creER/Stat3fl/fl mice. Stat3fl/fl and 
Cx3cr1creER/Stat3fl/fl mice received daily intragastric injection of 50 µg tamoxifen from P1-P3. A, B, D, 
Sagittal sections of P10 brain were stained with Hoechst and α-Iba-1 (green). Representative pictures are 
shown. Iba-1+ cells in the cerebral cortex were counted. Scale bar, 200 µm. Stat3fl/fl, n = 4; 
Cx3cr1creER/Stat3fl/fl, n = 3. C, E, P10 sagittal sections were stained with Nissl staining. Stat3fl/fl, n = 2. 
Cx3cr1creER/Stat3fl/fl, n = 2. F, G, P32 brain sagittal sections were stained with Hoechst and α-Iba-1 (F) 
or α-NeuN (G). Stat3fl/fl, n = 3. Cx3cr1creER/Stat3fl/fl, n = 3. Data represent mean ± SEM. **p < 0.01. 
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3.3.2 Behavioral Assessment of Mice with Neonatal Deletion of Microglial STAT3 
To assess possible behavioral changes resulting from the transient reduction of 
microglial number in neonatal Cx3cr1creER/Stat3fl/fl mice, multiple types of behavioral 
tests were performed at 4 weeks of age as well as Morris Water Maze (MWM) at 8 
weeks of age. The body weight was first measured at 4 weeks of age prior to the 
behavioral tests. No significant difference in the body weight was found between the 
Cx3cr1creER/Stat3fl/fl mice and Stat3fl/fl littermates (Figure 29A), indicating no major 
deficit in overall growth that could potentially be accountable for differences in 
behavioral performances. In the social interaction test, Cx3cr1creER/Stat3fl/fl and Stat3fl/fl 
mice spent roughly the same amount of time in the chamber with a novel stranger mouse 
(“Stranger”), in the opposite chamber (“Opposite”), as well as time spent in interacting 
with the novel stranger mouse (Figure 29B). In the marble burying test, the 
Cx3cr1creER/Stat3fl/fl mice buried significantly fewer marbles than Stat3fl/fl mice during 
the 30-minute testing period (Figure 29C). In the rotarod test, the Cx3cr1creER/Stat3fl/fl 
mice showed a trend of decreased ability to stay on the rod for all three days of testing, 
although no significant differences were found (Figure 29D). The Cx3cr1creER/Stat3fl/fl 
mice showed greater improvement in performance when compared to the Stat3fl/fl mice 
(Figure 29E), although this is likely due to a ceiling effect.  
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Figure 29. Behavioral tests in the Cx3cr1creER/Stat3fl/fl mice. P28 Stat3fl/fl (n = 7) and 
Cx3cr1creER/Stat3fl/fl mice (n = 14) were weighed (A) and tested for social interaction (B), marble 
burying (C), and rotarod (D, E). B, Mice were tested in the three-chamber device for 10 min. Stranger, 
total time spent in the chamber that contained a stranger mouse. Opposite, total time spent in the opposite 
chamber that contained an inversed metal mesh pencil holder. Interaction, total time spent sniffing the 
stranger mouse. C, Mice were placed in a cage with 2-inch deep of SANI-CHIP bedding and 10 marbles 
for 30 min. Total number of marbles that are at least 70% buried after the test was counted. D, Mice were 
placed in the rotarod device for 5 min per trial, 3 trials per day for 3 consecutive days. Cumulative time 
staying on the rod was graphed. Dashed line indicates maximum performance (900 s). E, Time spent on 
rod normalized to day 1 as an indication of improvement. Red **, performance of day 2 and day 3 
Cx3cr1creER/Stat3fl/fl mice compared to day 1 Cx3cr1creER/Stat3fl/fl mice. Data represent mean ± SEM. 
*p < 0.05. **p < 0.01. 
 
 
To evaluate the general activity and anxiety level of the Cx3cr1creER/Stat3fl/fl 
mice, multiple parameters of activity were analyzed during the 30-minute open field test 
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(Figure 30). Cx3cr1creER/Stat3fl/fl mice exhibited a very slight trend of decreased 
general activity, including the number of moves (Figure 30A) and jumps (Figure 30B), 
moving velocity (Figure 30D), total distance traveled (Figure 30E), time spent moving 
(Figure 30F), number of entries into the vertical plan (Figure 30H), and the time spent in 
the vertical plan (Figure 30I). However, the differences are modest and none is 
statistically significant. The mice of both genotypes also spent roughly the same amount 
of time in the margin versus the center (Figure 30F), and left the same amount of 
droppings during the test duration (Figure 30J), indicating no major difference in the 
level of anxiety in an open area. We also attempted separating the analysis by sex (male 
Stat3fl/fl , n  = 4; male Cx3cr1creER/Stat3fl/fl, n = 9; female Stat3fl/fl , n  = 9; female 
Cx3cr1creER/Stat3fl/fl, n = 14), and in both sexes we observed the same trend. 
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Figure 30. Open field test in the Cx3cr1creER/Stat3fl/fl mice. P28 Stat3fl/fl (n = 13) and 
Cx3cr1creER/Stat3fl/fl mice (n = 23) were placed in the open field device for 30 min. Parameters of 
measurements during the whole test period were computed. A, Number of moves. B, Number of jumps. C, 
Average distance per move. D, Speed when moving. E, Total, total moving distance. Margin, total moving 
distance while being in the margin area. Center, total moving distance while being in the center area, 
defined as being farther than 2.5 beams to the wall. F, Moving, total time spent moving. Resting, total time 
the coordination remain unchanged. Margin and center, total time spent in the margin or center area. G, 
Number of times the mouse crossed into the center area. H, Number of time the mouse raised its body to 
reach the upper sensor bar. I, Total time the mouse spent raising its body. J, Number of droppings was 
counted after the open field test. Data represent mean ± SEM. 
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To evaluate the spatial learning ability of the Cx3cr1creER/Stat3fl/fl mice, MWM 
was performed at 8 weeks of age (Figure 31). During the 6-day period for hidden 
platform training, the Stat3fl/fl mice improved performance from day 3 to day 5, as 
evidenced by the decrease in the time spent and distance traveled before locating the 
platform (Figure 31A, B). However, the performance drastically worsened on the last 
day of training (day 6). Moreover, the performance on day 5 was not necessarily better 
than day 1. Therefore, the training results may be due to natural variations, or the mice 
may not have been sufficiently trained. During the 6-day training period, there was a 
trend of the Cx3cr1creER/Stat3fl/fl mice spending longer time to locate the platform 
(Figure 31A). However, since the presence of a learning effect is questionable in the 
Stat3fl/fl mice, it cannot be concluded that Cx3cr1creER/Stat3fl/fl mice located the 
platform more slowly due to impaired spatial learning. Instead, this could be due to the 
trend that Cx3cr1creER/Stat3fl/fl mice swam more slowly (Figure 31C), thereby spending 
more time to locate the platform by chance. Two hours and a day after the last training, a 
probe test was performed in which the mice were placed back in the pool without the 
platform (Figure 31D, E). No significant difference was found in the proximity of the 
mouse to the now-absent platform during either of the probe tests (Figure 31D). 
Although the Cx3cr1creER/Stat3fl/fl mice spent significantly less time in the target 
quadrant, i.e., the quadrant of the pool where the platform used to be, the Stat3fl/fl mice 
only spent roughly 25% of the test time in the target quadrant (Figure 31E), indicating 
that no actual learning had occurred. 
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Figure 31. MWM test in the Cx3cr1creER/Stat3fl/fl mice. A-C, 8-week old Stat3fl/fl (n = 4) and 
Cx3cr1creER/Stat3fl/fl mice (n = 3) undertook 6 consecutive days of hidden platform training. A, Average 
time spent before locating the platform. B, Distance traveled before locating the platform. C, Swimming 
speed. D, E, 2 hr and 24 hr after the last hidden platform training, the mice undertook a probe test. D, The 
average distance to the platform within the first 5 s of the probe test. E, Percent time spent in the quadrant 
where the platform was previously placed. Data represent mean ± SEM. *p < 0.05. 
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3.4 Discussion 
In this section, the role of microglial STAT3 in the developing brain and 
behavioral consequences were investigated. First, Cx3cr1 promoter-driven Cre 
recombination upon P1-P3 administration of tamoxifen was determined to be highly 
efficient in the microglia, granulocytes, and Ly6Chi monocytes at P6 (Figure 27). Using 
this paradigm, Cx3cr1-mediated Stat3 ablation at P1-3 resulted in significant loss of 
microglial cells as determined by immunofluorescence microscopy and cell counting 
analysis (Figure 28). The mutant microglia also morphologically appeared to be in a 
more activated state than that of wildtype microglia at P10. Although the decreased 
microglial population at the second postnatal week essentially recovered and were 
morphologically similar to that of wildtype littermates in one-month old mice, the 
transient alterations of microglia in the Stat3 mutant mice during the early postnatal 
period appeared to have long term functional effects on certain behaviors. The innate 
marble burying activity was significantly impaired in the mutant mice, while social 
activity and locomotor functions remained unaffected (Figure 29, Figure 30). Although 
our pilot MWM test indicated that Stat3 mutant mice may have deficits in spatial 
learning and memory, due to insufficient training trials in this experiment, we consider 
these results inconclusive and require further investigation (Figure 31). Our study 
demonstrated that STAT3 activation is necessary for the normal development and 
function of microglia in the first two postnatal weeks, and that disruption of STAT3 
signaling pathway in the microglia may have persistent functional consequences. 
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Initially regarded as one type of glial cells that “fill in the space” in the CNS 
when first described, microglia have now been found to possess functions in multiple 
aspects of immunity and neural development. Specifically, loss of microglia during early 
postnatal stage has been shown to cause many behavioral deficits [137, 184, 186, 187]. 
In this study, disruption of STAT3 during neonatal stage caused a drastic reduction of 
microglial number in the cerebral cortex at P10 (Figure 32). Due to the pleotropic 
functions of STAT3, the mechanisms that cause the loss of microglia in the 
Cx3cr1creER/Stat3fl/fl mice require further investigation. STAT3 is known for its 
function in regulating genes related to promoting cell cycle. Specifically, STAT3 can 
promote cell proliferation as well as prevent programmed cell death [96, 97, 100-103]. It 
is possible that STAT3 promotes the proliferation and expansion of microglial 
population during the first postnatal week. Alternatively, STAT3 may contribute to 
microglia homeostasis by reducing programmed cell death in the microglia. It is also 
possible that STAT3 mediates M-CSF and/or IL-34 signaling, both of which have been 
shown to be important in microglial differentiation and survival [161, 200]. Since 
microglia become activated during the first two postnatal weeks, it is also possible that 
STAT3-mediated IL-10 anti-inflammatory responses prevent microglial cell death 
caused by overactivation. A logical next step of this study would be to investigate 
proliferation and programmed cell death in the microglia at various developmental 
stages. Alternatively, proliferation, programmed cell death, and activation status can also 
be tested using primary glial cultures prepared from Cx3cr1creER/Stat3fl/fl mice and 
wildtype controls.  
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Figure 32. Summary of targeted deletion of Stat3 in the microglia. 
 
 
In this study, our preliminary data indicate an increased neuronal cell number in 
the cortex. We also found that the mice deficient of microglial STAT3 exhibited 
impaired natural burying behavior. Since microglia are involved in regulating neuronal 
cell number, phagocytosis of cell debris, secretion of growth factors, refinement of 
synaptic connections and more, experimental depletion of microglia can cause a wide 
variety of developmental and behavioral abnormalities (reviewed by Frost and Schafer 
[212]). The reduction of microglial number in the STAT3-mutant mice could cause 
insufficient synaptic refinement and/or neural circuit maturation, which could then lead 
to impaired memory forming and natural behaviors. As a future direction, we plan to 
reveal neuronal structures including morphology of dendrites and axons with Golgi 
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staining at various developmental stages. In addition, cocultures with neurons and 
STAT3-mutant or wildtype microglia can help to investigate how neurons develop under 
the influence of mutant or wildtype microglia. These would help elucidate the 
underlying mechanisms of the abnormal natural behaviors in the microglial STAT3-
mutant mice. 
We utilized several types of behavioral tests were utilized to detect potential 
behavioral deficits in the Cx3cr1creER/Stat3fl/fl mice. Social interaction and marble 
burying tests are commonly used to test behaviors relevant to autism spectrum disorders 
and compulsive behaviors [209, 213]. The Cx3cr1creER/Stat3fl/fl mice did not show 
abnormalities in their social preferences in the social interaction test in this study. 
However, it is worth noting that different types of social interaction tests exist [214]. 
While the three-chamber social approach test utilized in this study is a standardized and 
well-established procedure, it offers fewer types of interaction measurement and is set in 
an environment unnatural to the tested mice. While a mouse under testing may be able to 
recognize and approach a novel mouse, this does not necessarily mean other social 
interactions, for example, following, pushing, or crawling over each other, are also 
unchanged. The chamber is transparent, has no food, water, bedding or smell of the 
home cage. It is thus possible that the mouse is stressed in such environment and is not 
ready to interact with a stranger yet. A refined social test with more natural settings will 
help to determine whether the Cx3cr1creER/Stat3fl/fl mice have altered social behaviors 
in relation to wildtype mice. 
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The Cx3cr1creER/Stat3fl/fl mice buried significantly fewer marbles during the 
marble burying test, suggesting that the mice are, if anything, displaying less compulsive 
behaviors. Although it would be tempting to speculate that the Cx3cr1creER/Stat3fl/fl 
mice display less anxiety-induced marble burying behavior, the interpretation of marble 
burying in terms of anxiety is controversial. Thomas and others [215] found that the 
marble burying test does not correlate with other anxiety related assays. If the marbles 
induce anxiety in the mouse, it may remain immobile rather than attempting to bury 
them. Therefore, other tests such as the open field or elevated maze test may be more 
suitable to assess anxiety. 
In the open field test, the Cx3cr1creER/Stat3fl/fl mice spent roughly 83% of the 
testing period in the margin area of the test chamber, similar to the Stat3fl/fl mice. While 
this may suggest that the mice do not have anxiety-related disorders, it is worth noting 
that the chamber size might not be ideal as an anxiety test. Indeed, several early reports 
utilized much larger chambers in their studies, i.e., 60 by 60 cm or 80 by 80 cm [216, 
217]. If the chamber is not large enough, the mouse may not interpret the margin as 
“safer” than the center and may instead think that it is trapped in the chamber. This is 
consistent with the observation in this study that during the test, some mice repetitively 
jumped as if trying to escape the chamber. Therefore, a future direction of this study 
would be to incorporate the elevated plus maze test, in which the mouse can either stay 
in the closed arm or explore into the open arm. 
The open field test is also used to measure locomotor activity [218]. The 
Cx3cr1creER/Stat3fl/fl mice only showed a slight trend towards fewer movements and 
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moving distance, indicating that their locomotor activity was not impaired. Similarly, no 
significant differences were found in the rotarod test, suggesting that the motor 
coordination was rather normal. However, during the rotarod test, a ceiling effect was 
observed in which most of the Stat3fl/fl mice were able to stay on the rod for the whole 
15-min duration on the third day of training, potentially impeding a difference to be 
found. Therefore, it would be best to repeat the rotarod test with increased maximum 
speed. 
In the MWM test, the Cx3cr1creER/Stat3fl/fl mice spent significantly less time in 
the target quadrant during the probe test. Unfortunately, the Stat3fl/fl mice did not even 
spend more than 25% of the testing period in the target quadrant, and over the six 
training days the mice had not improved their performance. Therefore, it is not possible 
to draw conclusions to this experiment. MWM is a complex test in which many factors, 
such as even changing the testing room can drastically affect the performance [210]. As 
such, our MWM test needs to be improved so that the spatial learning behaviors could be 
observed. For example, a more extensive visible platform training prior to the hidden 
platform training period could help the mice learn that once in water, there is a platform 
to look for. Because the MWM is a stressful test and the mice could give up when too 
stressed, it is important to maintain a sufficiently intensive training schedule while 
minimizing other stress-inducing factors. Gentle handling and the use of temperature 
controlled water should help to reduce stress. It is also important that the visual cues are 
large enough, have enough contrast, and are situated at a height that can be seen by the 
mice. Last but not the least, a probe test should be carried out prior to the first day of 
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hidden platform training, so there is a baseline performance to compare the before-and-
after effect.  
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4. CONCLUSIONS 
 
4.1 The Role of Myeloid STAT3 in EAE 
MS is a CNS demyelinating and neurodegenerative disease that involves 
unknown etiology. Although MS likely involves both genetic and environmental factors, 
it is not attributable to one single gene, and to date no one infectious agent has been 
identified that can cause the disease. Furthermore, although MS likely involves 
autoimmunity, it is yet to be proven as a purely autoimmune-driven disease, and no 
single self-antigen has been identified. Various animal models exist to help study 
different aspects of MS. EAE is an autoimmune-driven model and due to its reliability of 
induction, relatively short experimental period, and availability in the C57BL/6 
background in which many transgenic lines are, EAE is the most widely used model for 
MS. Although EAE has been criticized for its limited applicability to MS etiology, 
studies in EAE have greatly advanced our knowledge in autoimmune demyelination. 
Stat3 gene is a risk factor for MS, and its role in differentiation of TH17 cells, one of the 
most important cell types in EAE pathogenesis, has been established. Myeloid cells are 
also important in the development of EAE, and STAT3 activation has been shown to be 
increased in the monocytes of relapsing MS patients. However, the specific functions of 
STAT3 in the myeloid cells in EAE remains to be elucidated. To address this gap in 
knowledge, we set out to study the functions of myeloid STAT3 by generating 
conditional deletion of STAT3 using the LysMcre/Stat3fl/fl mice. 
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We first demonstrated that myeloid-specific STAT3 deletion confers a strong 
resistance to EAE. Most of the LysMcre/Stat3fl/fl mice did not show signs of classic EAE 
clinical symptoms, demyelination, or leukocyte infiltration. We also found that the 
helper T-cell responses in the peripheral lymphoid organs were decreased. Since helper 
T-cell responses are critically important in EAE such that they are not only necessary, 
but sufficient to induce EAE alone, we hypothesized that STAT3-deficient myeloid cells 
show impaired capability to differentiate helper T-cells. 
Next, to test the capability of the STAT3-deficient myeloid cells to help 
differentiate helper T-cells into effector T-cell subsets, we took an ex vivo approach and 
co-cultured the myeloid cells with naïve 2D2 T-cells in the presence of the antigen 
MOG. We found that STAT3-deficient myeloid cells did not sufficiently differentiate 
the T-cells. We also found that the myeloid cells expressed less antigen-presenting and 
co-stimulatory molecules, likely resulting in the deficit in T-cell differentiation. 
To test whether the deficit in generating effector T-cells is indeed accountable to 
the EAE resistance in the LysMcre/Stat3fl/fl mice, we conducted passive EAE induction 
by adoptive transfer of autoreactive T-cells, thereby bypassing the need to generate the 
host’ own effector T-cells upon immunization. We found that two thirds of the 
LysMcre/Stat3fl/fl mice developed adoptive transfer EAE, indicating that the impaired T-
cell responses are at least partially responsible to the EAE resistance. 
Last, since it’s been reported that microglia exhibit differential responses than 
infiltrating myeloid cells during EAE, we generated a more specific microglial STAT3 
deletion by utilizing the Cx3cr1creER mice. We observed a trend towards decreased 
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average clinical scores in the Cx3cr1creER/Stat3fl/fl mice. However, the difference was 
not statistically significant. 
Our study sheds light on the role of myeloid STAT3 in generation of 
autoimmune T-cell responses. Particularly, the impaired capability of STAT3-deficient 
myeloid cells to differentiate helper T-cells into effector subsets resulted in greatly 
reduced susceptibility to EAE. Future studies will be required to determine the 
downstream genes regulated by STAT3 that are important in the myeloid cell functions, 
as well as the potential differential functions of STAT3 in different subtypes of myeloid 
cells, such as neutrophils, dendritic cells, or monocytes. Additionally, since the partial 
susceptibility to adoptive transfer EAE suggests alternative mechanisms, another future 
direction would be to investigate other potential influences STAT3 has in the myeloid 
cells, such as the transmigrating capability. 
 
4.2 The Role of Microglial STAT3 in Early Postnatal Development 
Microglia are one of the tissue-resident macrophages that emerge from the yolk 
sac during primitive hematopoiesis. Since their initial discovering, microglia have been 
increasingly appreciated for their diverse roles in the neural development in the CNS. 
Studies that depleted microglia in the early postnatal period discovered abnormal brain 
structures as well as behavioral deficits in the animals. STAT3 is a transcription factor 
that are involved in genes that regulate cell cycle and inflammation. To investigate 
whether microglial STAT3 has a role in microglial cell survival and/or activation status 
and how this would translate to neural development, we set out to study microglial 
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STAT3 functions by inducing neonatal deletion of STAT3 in microglia in the 
Cx3cr1creER/Stat3fl/fl mice. 
We discovered that neonatal deletion of microglial STAT3 results in a transient 
reduction of microglial number at P8-P10. In our limited analysis, we also found 
moderately increased number of cortical neuron cells. Although such difference was no 
longer observed at P32, the transient reduction in microglial number during the first two 
postnatal weeks likely have caused developmental abnormalities, which could then lead 
to persistent functional consequences. Indeed, we also found that the mice with 
microglial STAT3 deletion at neonatal age exhibited impaired marble burying behavior 
in young adulthood, indicating altered anxiety level and/or repetitive behaviors. 
Although so far we found a difference only in the marble burying test, some of the 
behavioral tests we employed, e.g., the Morris’ Water Maze, had not been sufficiently 
optimized to be able to test the intended behaviors. We plan to refine these behavioral 
tests as well as incorporating more tests, such as the elevated plus maze, so that other 
potential behavioral consequences in the disruption of neonatal microglial STAT3 
activation can be identified. 
Our study highlights the importance of STAT3 activation during the normal 
development and function of microglia in the first two postnatal weeks, and that 
disruption of STAT3 signaling pathway in the microglia may have persistent functional 
consequences. Future studies would be required to investigate the mechanism that 
STAT3 is involved in maintaining microglia homeostasis during development, as well as 
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to identify the developmental and structural abnormalities in the neurons caused by 
neonatal microglial STAT3 inactivation. 
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